DSM-5 criteria for substance use disorders: recommendations and rationale.
paper
Cited
Public
- Authors
- Hasin, Deborah S; O'Brien, Charles P; Auriacombe, Marc; Borges, Guilherme; Bucholz, Kathleen; Budney, Alan; Compton, Wilson M; Crowley, Thomas; Ling, Walter; Petry, Nancy M; Schuckit, Marc; Grant, Bridget F
- Year
- 2013
- Journal
- The American journal of psychiatry
- PMID
- 23903334
- DOI
- 10.1176/appi.ajp.2013.12060782
- PMCID
- PMC3767415
Since DSM-IV was published in 1994, its approach to substance use disorders has come under scrutiny. Strengths were identified (notably, reliability and validity of dependence), but concerns have also arisen. The DSM-5 Substance-Related Disorders Work Group considered these issues and recommended revisions for DSM-5. General concerns included whether to retain the division into two main disorders (dependence and abuse), whether substance use disorder criteria should be added or removed, and whether an appropriate substance use disorder severity indicator could be identified. Specific issues included possible addition of withdrawal syndromes for several substances, alignment of nicotine criteria with those for other substances, addition of biomarkers, and inclusion of nonsubstance, behavioral addictions.This article presents the major issues and evidence considered by the work group, which included literature reviews and extensive new data analyses. The work group recommendations for DSM-5 revisions included combining abuse and dependence criteria into a single substance use disorder based on consistent findings from over 200,000 study participants, dropping legal problems and adding craving as criteria, adding cannabis and caffeine withdrawal syndromes, aligning tobacco use disorder criteria with other substance use disorders, and moving gambling disorders to the chapter formerly reserved for substance-related disorders. The proposed changes overcome many problems, while further studies will be needed to address issues for which less data were available.
DSM-IV and DSM-5 Criteria for Substance Use Disordersa One or more abuse criteria within a 12-month period and no dependence diagnosis; applicable to all substances except nicotine, for which DSM-IV abuse criteria were not given.b Three or more dependence criteria within a 12-month period.c Two or more substance use disorder criteria within a 12-month period.d Withdrawal not included for cannabis, inhalant, and hallucinogen disorders in DSM-IV. Cannabis withdrawal added in DSM-5.
LLM interpretation
This figure is a comparison table outlining the diagnostic criteria for substance use disorders across DSM-IV (Abuse and Dependence) and DSM-5. It lists specific behavioral and physiological symptoms in the first column, using "X" marks to indicate which criteria apply to each diagnostic category. Brackets indicate the minimum number of criteria required for a diagnosis: $\ge 1$ for DSM-IV Abuse, $\ge 3$ for DSM-IV Dependence, and $\ge 2$ for DSM-5 Substance Use Disorders.
Information Characteristic Curves from Item Response Theory Analysis of DSM-IV Alcohol Abuse and Dependence Criteria, Required to Persist Across 3 Years of Follow-Upa,ba Red curves: DSM-IV abuse criteria. Black curves: DSM-IV dependence criteria. Blue curve: Craving.b Data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), Wave 2 (2004โ2005), conducted by the National Institute on Alcohol Abuse and Alcoholism. Participants were noninstitutionalized civilians age 20 years and older (N=34,653). The NESARC had a multistage design and oversampled blacks, Hispanics, and young adults. Analyses were conducted with Mplus (version 6.12, Los Angeles, Muthรฉn & Muthรฉn, 2011) and incorporated sample weights to adjust standard errors appropriately. See supplementary Table S2 for more detail on this analysis.
LLM interpretation
This figure consists of multiple item characteristic curves plotting the probability of criterion endorsement (y-axis) against latent trait severity (x-axis). The curves are categorized by color: red for DSM-IV abuse criteria, black for DSM-IV dependence criteria, and blue for craving. The curves generally follow a sigmoidal pattern, with different criteria shifting along the x-axis to indicate varying levels of severity required for endorsement.
| # | Section | Preview |
|---|---|---|
| 60 | Present Status and Future Directions | The statistical methodology used to examine the structure of abuse and dependence criteria was stateโฆ |
| 61 | Present Status and Future Directions | The amount of data available to address the topics discussed above varied, and new studies will beโฆ |
โ Prev
61โ62 of 62
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Association between processing speed and segregation/integration of large-scale functional networks in middle-aged and older people living with HIV. | Diaz MM et al. | โ | 2026 | โ |
| Ausprรคgung und Korrelate des Rauchverhaltens bei Patientinnen und Patienten mit Substanzkonsumstรถrung in einer jugendpsychiatrischen Spezialambulanz. | Teichmann M et al. | โ | 2026 | โ |
| Cannabis flower, concentrates, and edibles: a narrative review comparing prevalence of use, methods of consumption, and cannabis use disorder outcomes. | Inman A et al. | โ | 2026 | โ |
| Cannabis use in pregnancy: Key findings from 2021-2023 National Survey on Drug Use and Health data. | Wysota CN et al. | โ | 2026 | โ |
| Celebrating each success: proportion of remission as a measure of recovery from polysubstance use disorder proportion of remission; a recovery measure. | Quddos F et al. | โ | 2026 | โ |
| Centrally Mediated Disorders of Gastrointestinal Pain. | Fukudo S et al. | โ | 2026 | โ |
| Daily Life Assessment of Seven Alcohol-Use-Disorder Symptoms. | Kang D et al. | โ | 2026 | โ |
| Descriptive content analysis assessment of ChatGPT responses to substance use disorder treatment questions compared to National health guidelines. | Decker M et al. | โ | 2026 | โ |
| Diagnostic accuracy of the alcohol use disorders identification test (AUDIT) in Swedish young adult outpatients in general psychiatry. | Lenninger S et al. | โ | 2026 | โ |
| Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology. | Sinclair JM et al. | โ | 2026 | โ |
| Examination of the DSM-5 level 2 substance use measure using Rasch modeling with United States parents. | Donovan C et al. | โ | 2026 | โ |
| Exploring gender differences in tobacco cue-induced craving and heart rate variability in individuals with a tobacco use disorder. | Hoffmann L et al. | โ | 2026 | โ |
| Exploring neural markers of incentive salience and real-world drinking among individuals with alcohol use disorder. | Kang D et al. | โ | 2026 | โ |
| High-risk profiles for polysubstance use among veterans: Associations of depression, generalized anxiety disorder, and sexual assault in a clinical cohort. | Flynn AJ et al. | โ | 2026 | โ |
| Impact of psychedelics on craving in addiction: A systematic review. | Chapron SA et al. | โ | 2026 | โ |
| Implementing Care for Cannabis and Other Drug Use in Adult Primary Care: Outcomes of a Cluster-Randomized Implementation Trial. | Matson TE et al. | โ | 2026 | โ |
| Judith and Holofernes: alcohol's role in male sexual health in the light of the systems sexology. | Yannas D et al. | โ | 2026 | โ |
| Patterns and Correlates of Co-occurring Smoking, Alcohol Use, Gambling, and High Internet Use Among University Students: A Cross-Sectional Study in Tรผrkiye. | Avcu AB et al. | โ | 2026 | โ |
| Patterns of structural brain differences in cocaine use disorder: Integrating multilevel frequentist, Bayesian, and coordinate-based meta-analyses. | Bittencourt AML et al. | โ | 2026 | โ |
| Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. | Bedillion MF et al. | โ | 2026 | โ |
| Productivity Losses From Substance Use Disorder in the U.S. in 2023. | Ghimire R et al. | โ | 2026 | โ |
| Racial diversity in cannabis use disorder research: A systematic review. | Reid MR et al. | โ | 2026 | โ |
| Real-Time and Long-Term Effects of Medical Marijuana on Older Adults: Protocol for a Prospective Cohort Study. | Robinson KR et al. | โ | 2026 | โ |
| Sex-Based Disparities in Health Outcomes and Pandemic-Related Stressors Among Persons with Substance Use Disorders: Findings from the National Survey on Drug Use and Health, 2021. | Moore B et al. | โ | 2026 | โ |
| Stimulant use disorder indicative of increased serum soluble intercellular adhesion molecule-1 concentrations with altered brain reward and interoceptive processing. | Burrows K et al. | โ | 2026 | โ |
| The addicted brain: How processed foods hijack reward pathways. | Hough K et al. | โ | 2026 | โ |
| The DNA methylation enzymatic machinery in substance use disorders: A systematic review. | Diringer M et al. | โ | 2026 | โ |
| The effect of cannabis use on the time course of positive and negative affect in the daily life of youth. | Emery NN et al. | โ | 2026 | โ |
| The modulatory effects of design-related and clinical factors in neural drug cue reactivity: An ALE meta-analysis. | Fascher M et al. | โ | 2026 | โ |
| The psychometric properties of validated tools to assess cannabis use disorder: A systematic review and meta-analysis. | Leung J et al. | โ | 2026 | โ |
| Tobacco cessation prescription rates among Veterans living with human immunodeficiency virus who smoke. | Herbst E et al. | โ | 2026 | โ |
| Utilizing multimodal cortical parcellations to identify novel regions of the human cerebral cortex associated with substance use disorders. | Qiu S et al. | โ | 2026 | โ |
| A case against purity: prioritizing translational polysubstance use research. | Gipson CD et al. | โ | 2025 | โ |
| Addiction Susceptibility: Genetic Factors, Personality Traits, and Epigenetic Interactions with the Gut Microbiome. | Borrego-Ruiz A et al. | โ | 2025 | โ |
| Addiction to Cosmetic Procedures: A Scoping Literature Review. | Wagenaar W et al. | โ | 2025 | โ |
| A multicenter cross-sectional study of gambling disorder among patients with methamphetamine use disorder in drug rehabilitation centers: prevalence, correlates, and network analysis. | Peng P et al. | โ | 2025 | โ |
| Analyzing the Successful Incompetent to Be Executed Cases in the United States: A First Pass. | Su IA et al. | โ | 2025 | โ |
| A Perinatal Review of Prevalence and Risk Factors for Substance Abuse Among Pregnant Women in Singapore. | Lee RWK et al. | โ | 2025 | โ |
| A Randomized Comparison Trial Testing Two Culturally Adapted HIV Prevention Approaches for Native Americans Reducing Trauma Symptoms Versus Substance Misuse. | Pearson CR et al. | โ | 2025 | โ |
| Assessing the efficacy of nanoparticles in reversing opioid poisoning and preventing renarcotization. | Manes A et al. | โ | 2025 | โ |
| Assessment of alcohol and tobacco use in psychotherapy: validation of the german self-report ASSIST alcohol and tobacco subscales in an outpatient setting. | Sรผnkel E et al. | โ | 2025 | โ |
| Association Between Prior Substance Use and Sedation and Analgesia Requirements Among Mechanically Ventilated Adults With Critical Illness. | Feeney ME et al. | โ | 2025 | โ |
| A Survey of Adolescent and Caregiver Perceptions of Substance Use Screening in Pediatric Emergency Departments. | Sandelich S et al. | โ | 2025 | โ |
| A Treatment Mobile App for Sexual Minority Men Who Use Methamphetamine Demonstrates Reductions in Methamphetamine Use and HIV Sexual Risk Behaviors: Getting Off. | Reback CJ et al. | โ | 2025 | โ |
| Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity. | Shi Z et al. | โ | 2025 | โ |
| Cannabis Use Among Older Adults. | Pravosud V et al. | โ | 2025 | โ |
| Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013. | Hasin DS et al. | โ | 2025 | โ |
| Cannabis Use and Clinical Outcomes in Adolescents and Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study. | Roberts AJ et al. | โ | 2025 | โ |
| Cannabis Use in Adolescents. | Bhangu GK et al. | โ | 2025 | โ |
| Changes in the trajectories of drug-free friendships and substance use among a cohort of individuals with multiple substance use disorders. | Moe FD et al. | โ | 2025 | โ |
| Characteristics of adolescent cannabis use and social context predicting problematic use: A decision tree analysis. | Battista K et al. | โ | 2025 | โ |
| Clinical Characteristics of Health Professions Students with Nitrous Oxide Use Disorder. | Angerville B et al. | โ | 2025 | โ |
| Clinical Drug Testing Supporting Patients with Substance Use Disorder: A Review. | Saitman A | โ | 2025 | โ |
| Cocaine craving and use during pharmacotherapy trials for cocaine use disorder: A multi-trajectory analysis. | Mojtabai R et al. | โ | 2025 | โ |
| Common neural patterns of substance use disorder: a seed-based resting-state functional connectivity meta-analysis. | Zhang X et al. | โ | 2025 | โ |
| Comprehensive Management of Cocaine-Induced Midline Destructive Lesions: A Young-IfOS Consensus. | Saibene AM et al. | โ | 2025 | โ |
| Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches. | Bonner-Reid FT et al. | โ | 2025 | โ |
| Correlations between wastewater levels of naloxone and substance use disorder treatment medications with treatment encounters and overdoses - Marin County, California, USA, March 2023-June 2024. | Hannah H et al. | โ | 2025 | โ |
| Cue reactivity towards distal cues in specific types of problematic usage of the internet: findings from diagnostically validated samples. | Antons S et al. | โ | 2025 | โ |
| Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for DSM-5 stimulant use disorder. | Chung AKK et al. | โ | 2025 | โ |
| Differences in fMRI-based connectivity during abstinence or interventions between heroin-dependent individuals and healthy controls. | Kurtin DL et al. | โ | 2025 | โ |
| Differentiating Opioid Use Disorder from Chronic Pain in Sickle Cell Disease: A Diagnostic Challenge. | Yan X et al. | โ | 2025 | โ |
| Dual Role of LH-GABA Neurons in Encoding Alcohol Reward and Aversive Memories. | Alonso-Lozares I et al. | โ | 2025 | โ |
| Dynamic symptom networks in etomidate use disorder: a cross-lagged panel network analysis of craving, compulsive drug seeking, and cognitive control. | Le J et al. | โ | 2025 | โ |
| Effectiveness of Psychosocial Interventions in Alcohol and Substance Use Disorders: A Meta-Analysis Study. | Helvacฤฑ รelik FG et al. | โ | 2025 | โ |
| Effects of scarcity on women's cognitive ability to manage mental health and substance use after prison release. | Johnson JE et al. | โ | 2025 | โ |
| Enhancing Emotion Regulation and Overcoming Craving in Alcohol Dependence Syndrome Through Mindfulness-based Relapse Prevention. | Riya et al. | โ | 2025 | โ |
| Epidemiology of Substance-Related Admissions to ICUs in the United States. | Hills-Dunlap K et al. | โ | 2025 | โ |
| Ethanol self-administration reduced the efficacy of a behavioral intervention to decrease cocaine choice in socially housed male and female monkeys. | Rough MI et al. | โ | 2025 | โ |
| Evaluation of acute substance abuse patients admitted to the ICU by different scoring system. | El Sehly WMM et al. | โ | 2025 | โ |
| Evaluation of glycine treatment for reducing alcohol craving and self-administration in individuals with alcohol use disorder: A human laboratory trial. | Olsson Y et al. | โ | 2025 | โ |
| Exploring Cortical Interneurons in Substance Use Disorder: From Mechanisms to Therapeutic Perspectives. | Shi S et al. | โ | 2025 | โ |
| Exploring the Gut and Oral Microbiomes in Psychoactive Substance Use: A Scoping Review of Clinical Studies. | Barkus A et al. | โ | 2025 | โ |
| Exploring the relationship between cue-induced craving and withdrawal craving in MUD individuals based on a virtual-reality cue exposure paradigm. | Huang Q et al. | โ | 2025 | โ |
| Exploring the therapeutic potential of psychedelics in treating substance use disorders. | Li Y et al. | โ | 2025 | โ |
| Food for thought: The relationship between poor eating habits, delay discounting, and quality of life in substance use recovery. | Cabral DAR et al. | โ | 2025 | โ |
| "General Addiction Liability" Revisited. | Watts AL et al. | โ | 2025 | โ |
| Genetic risk for alcohol use disorder in relation to individual symptom criteria: Do polygenic indices provide unique information for understanding severity and heterogeneity? | Sarles YM et al. | โ | 2025 | โ |
| Global and regional burden of four drug use disorders in the elderly, 1990 to 2021: an analysis of the global burden of disease study. | Jia B et al. | โ | 2025 | โ |
| Gut microbiome depletion modulates cocaine-induced behavioral and transcriptional responses in female mice. | Dave YA et al. | โ | 2025 | โ |
| Home-based detoxification for individuals with alcohol or drug dependence: A systematic review of the recent literature. | Rens E et al. | โ | 2025 | โ |
| Identification of Plasma Metabolites Responding to Oxycodone Exposure in Rats. | Vu T et al. | โ | 2025 | โ |
| Impact of Opium Addiction on Liver Function and Biliary Tract in Patients with Bile Duct Stones: A Case-Control Study. | Abedinzadeh M et al. | โ | 2025 | โ |
| Implications of the shift to DSM-5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health. | Bailey AJ et al. | โ | 2025 | โ |
| Integrative exploration of bio-psycho-social determinants of DSM-5 severity levels of opioid use disorder: the BEBOP cohort study protocol. | Lalanne L et al. | โ | 2025 | โ |
| Letter: Safety and Tolerability of Injectable Extended Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease. | Bai X et al. | โ | 2025 | โ |
| Management of pregnant patients with substance use disorder. | Shafai A et al. | โ | 2025 | โ |
| Medications for Opioid Use Disorder in People Who Inject Substances: Reflection on the Potential Place of Morphine Sulfate as Substitution Treatment? Results of COSINUS Cohort Study. | Lalanne L et al. | โ | 2025 | โ |
| Met and unmet needs of service users with substance use disorders: a latent class analysis. | Chantry M et al. | โ | 2025 | โ |
| Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001-2019. | Bushnell G et al. | โ | 2025 | โ |
| Network analysis of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) 3.1 items for non-medical use of alcohol, tobacco, cannabis, prescription sedatives, prescription stimulants, and prescription opioids. | Shmulewitz D et al. | โ | 2025 | โ |
| Neural evidence of implicit emotion regulation deficits: An explorative study of comparing PTSD with and without alcohol dependence. | Zhao J et al. | โ | 2025 | โ |
| Neurobiological Mechanisms of Action of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Substance Use Disorders (SUDs)-A Review. | Chmiel J et al. | โ | 2025 | โ |
| Neuropsychological Instruments and Tasks for Dependence Behaviors in Medication-Overuse Headache. | Lau CI et al. | โ | 2025 | โ |
| Opioid dependence in patients with pain in chronic pancreatitis an emerging problem. | Manrai M et al. | โ | 2025 | โ |
| Opioid reward and deep brain stimulation of the lateral hypothalamic area. | Fattahi M et al. | โ | 2025 | โ |
| Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS. | Greydanus DE et al. | โ | 2025 | โ |
| Opioid use disorder, pain, and cognitive impairment in older adults who have experienced homelessness. | Breder K et al. | โ | 2025 | โ |
| Opium addiction is associated with increased risk of ERCP-related complications: A matched case-control study. | Sadeghi A et al. | โ | 2025 | โ |
| Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post-legalization era. | Bahji A | โ | 2025 | โ |
| Perioperative management of the patient on cannabis and cannabinoids: A review. | Scheuermann M et al. | โ | 2025 | โ |
| Personality predictors of exercise addiction in competitive sport. | Vรญtkovรก T et al. | โ | 2025 | โ |
| Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective Na<sub>V</sub>1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain. | Osteen JD et al. | โ | 2025 | โ |
| Planned versus Unplanned Daily Substance Use among Sexual Minority Youth: The Moderating Role of Social Norms. | Mereish EH et al. | โ | 2025 | โ |
| Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data. | Serre F et al. | โ | 2025 | โ |
| Prenatal opioid exposure alters pain perception and increases long-term health risks in infants with neonatal opioid withdrawal syndrome. | Radhakrishna U et al. | โ | 2025 | โ |
| Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years. | Han B et al. | โ | 2025 | โ |
| Psychiatrists' opinions about non-medicalization of cannabis use disorder in Iran. | Namazi H et al. | โ | 2025 | โ |
| Quantity of delta-9-tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. | Borodovsky JT et al. | โ | 2025 | โ |
| Racial and Ethnic Discrimination and DSM-5 Substance Use Disorders Among U.S. Adults. | Mattingly DT et al. | โ | 2025 | โ |
| Rasch Analysis of Cannabis Use Disorder in an Adult Inpatient Sample. | Gendy MNS et al. | โ | 2025 | โ |
| Rasch analysis of DSM-5 alcohol use disorder in a large inpatient sample. | Britton EM et al. | โ | 2025 | โ |
| Real-Time and Long-Term Effects of Medical Marijuana on Older Adults: Protocol for the Study on Medical Marijuana and its Long-Term Effects (the SMILE study) Prospective Cohort. | Robinson KR et al. | โ | 2025 | โ |
| Recent advances in nanotherapeutics for HIV-associated neurocognitive disorders and substance use disorders. | Lomas C et al. | โ | 2025 | โ |
| Reevaluating the brain disease model of addiction. | Blithikioti C et al. | โ | 2025 | โ |
| Risk factors and predictive score for phenytoin-induced cutaneous reactions. | Anamnart C et al. | โ | 2025 | โ |
| Risk of Substance Use Among LGBTQI+ Community Affected by Lifetime and Day-to-day Discrimination - Results from a Cross-sectional Study Performed in South India. | Ramanathan D et al. | โ | 2025 | โ |
| Rumination and drug craving scores in Chinese male patients with methamphetamine and heroin use disorders: a cross-sectional study. | Mao Y et al. | โ | 2025 | โ |
| Severity of Betel Quid Use Disorders (BUD) Among Adult Indian Betel Quid Chewers. | Petti S et al. | โ | 2025 | โ |
| Substance use and generalized anxiety disorder in university students: evidence from the university of Douala, Cameroon. | Magnerou AM et al. | โ | 2025 | โ |
| Synthetic cannabinoid use among noninstitutionalized individuals in the United States, 2021-2023. | Palamar JJ et al. | โ | 2025 | โ |
| The association between substance use and attention-deficit/hyperactivity disorder and borderline personality disorder in undergraduate students: An exploratory study. | Das J et al. | โ | 2025 | โ |
| The association of opioid prescribing continuity and the risk of opioid use disorder among older adults. | Prajapati P et al. | โ | 2025 | โ |
| The Impact of Substance Use Disorder and Drug Transfer into Breast Milk: Implications for Maternal and Infant Health. | Yang Y et al. | โ | 2025 | โ |
| The neural circuits and signalling pathways of opioid use disorder. | Mathis VP et al. | โ | 2025 | โ |
| The relationship between photo retouching addiction and social appearance anxiety for social internet users. | Yan D et al. | โ | 2025 | โ |
| The role of craving in gambling behavior: examining its relevance and links to psychological distress, personality, and demographics. | Westerberg T et al. | โ | 2025 | โ |
| The silence of opioids-dependent chronic pain patients: A text mining analysis from sex and gender perspective. | Carratalรก C et al. | โ | 2025 | โ |
| Treatment Use Among U.S. Adults with a Substance Use Disorder: Associations with Symptom Severity, Problem Self-Perception, Comorbid Mental Illness, and Mental Health Treatment. | Choi NG et al. | โ | 2025 | โ |
| Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030. | Jiang W et al. | โ | 2025 | โ |
| U.S. Adolescents' Daily Social Media Use and Well-being: Exploring the Role of Addiction-like Social Media Use. | Burnell K et al. | โ | 2025 | โ |
| 12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use. | Compton WM et al. | โ | 2024 | โ |
| A comprehensive evaluation of the neurocognitive predictors of problematic alcoholย use, eating, pornography, and internet use: A 6-month longitudinal study. | Christensen E et al. | โ | 2024 | โ |
| Acute Subjective Experiences of Intravenous Ketamine Therapy Among Medically Hospitalized Patients with Alcohol Use Disorder. | Terasaki D | โ | 2024 | โ |
| Advances in the management of alcohol-associated liver disease. | Anouti A et al. | โ | 2024 | โ |
| Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin. | Singal AK et al. | โ | 2024 | โ |
| An electroencephalographic signature predicts craving for methamphetamine. | Tian W et al. | โ | 2024 | โ |
| Assessing the effectiveness of brief interventional group therapy on severity of illness, readiness for change, self-efficacy and motivation levels in patients with alcohol use disorder: A pre-post study. | Bagde R et al. | โ | 2024 | โ |
| Association between drug craving and aggression in Chinese male methamphetamine-dependent patients with and without depressive symptoms. | Li D et al. | โ | 2024 | โ |
| Association Between Smartphone Usage and Primary Headaches in Taif, Saudi Arabia: A Hospital-Based Study. | Mubaraki AA et al. | โ | 2024 | โ |
| Association of current substance use treatment with future reduced methamphetamine use in an observational cohort of men who have sex with men in Los Angeles. | Rosen AD et al. | โ | 2024 | โ |
| Association patterns of antisocial personality disorder across substance use disorders. | Low A et al. | โ | 2024 | โ |
| Behavioral economic and wellness-based approaches for reducing alcohol use and consequences among diverse non-student emerging adults: study protocol for Project BLUE, a randomized controlled trial. | Murphy JG et al. | โ | 2024 | โ |
| Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality. | Alvarado-Tapias E et al. | โ | 2024 | โ |
| Biochemical and Pharmacological Assessments of Tramadol Abuse on Human Male Fertility: Relation to Seminal Plasma 8-Hydroxyguanosine and Zinc. | Hassan MH et al. | โ | 2024 | โ |
| Caffeine intake and anxiety: a meta-analysis. | Liu C et al. | โ | 2024 | โ |
| Cannabis use disorder: from neurobiology to treatment. | Le Foll B et al. | โ | 2024 | โ |
| Clinical and Neuropathological Correlates of Substance Use in American Football Players. | Walsh M et al. | โ | 2024 | โ |
| Clinical cutoffs of the Alcohol Use Disorder Identification Test for identification of DSM-5 alcohol use disorder: A psychometric evaluation in treatment-seeking patients. | Ingesson-Hammarberg S et al. | โ | 2024 | โ |
| Comparison between cytisine and Nicotine Replacement Therapy in smoking cessation among inpatient psychiatric patients. | Tavakoli-Ardakani M et al. | โ | 2024 | โ |
| Co-occurrence of problematic facebook and video game use: prevalence and association with mental health disorders among adolescents. | Fredj SB et al. | โ | 2024 | โ |
| Couple-Focused Smartphone Intervention to Reduce Problem Drinking: Pilot Randomized Control Trial. | Gustafson DH et al. | โ | 2024 | โ |
| Craving changes in first 14 days of addiction treatment: an outcome predictor of 5 years substance use status? | Baillet E et al. | โ | 2024 | โ |
| Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement. | Lee BP et al. | โ | 2024 | โ |
| Developmental changes in brain function linked with addiction-like social media use two years later. | Flannery JS et al. | โ | 2024 | โ |
| Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings. | Hamilton LK et al. | โ | 2024 | โ |
| Does This Patient Have Alcohol Use Disorder?: The Rational Clinical Examination Systematic Review. | Wood E et al. | โ | 2024 | โ |
| Effectiveness evaluation of an organisational intervention, targeting pregnancy and addiction care professionals, among women who have just given birth in maternity wards and smoked tobacco during pregnancy (5A-QUIT-N): study protocol for a stepped-wedge cluster randomised trial. | Kervran C et al. | โ | 2024 | โ |
| Effect of HIV and substance use disorder comorbidity on the placenta, fetal and maternal health outcomes: systematic review and meta-analysis protocol. | Sorato MM et al. | โ | 2024 | โ |
| Examination of the mild, moderate, and severe alcohol use disorder severity indicators using a nationally representative sample. | Bailey AJ et al. | โ | 2024 | โ |
| Examining the Potential Impact of Recreational Cannabis Legalization on Individuals Receiving Treatment for Substance Use Disorder: An Interrupted Time Series Study in Guelph, Ontario, Canada. | Britton EM et al. | โ | 2024 | โ |
| Excess dietary sugar and its impact on periodontal inflammation: a narrative review. | Shanmugasundaram S et al. | โ | 2024 | โ |
| Exploring Racial/Ethnic Disparities in Substance Dependence and Serious Psychological Distress among US Veterans. | Lawson SC et al. | โ | 2024 | โ |
| Exploring the diversityย of uncommon oral yeast species andย associated risk factorsย among substance abusers inย southwestern Iran. | Ghojoghi A et al. | โ | 2024 | โ |
| Factors Related to Receipt of Help for Alcohol Use: Extending the Focus of Treatment to the Continuum of Unhealthy Alcohol Use. | Tieu L et al. | โ | 2024 | โ |
| Generalized genetic liability to substance use disorders. | Miller AP et al. | โ | 2024 | โ |
| Genetic association of SLC6A3 (dopamine transporter) gene polymorphisms with personality disorders and substance abuse disorders: a systematic review and meta-analysis. | Vogiatzoglou AV et al. | โ | 2024 | โ |
| Higher Prevalence Estimates of Substance Use Disorders With DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use: The Role of DSM-IV Diagnostic Orphans. | Hasin D et al. | โ | 2024 | โ |
| How can we measure gambling craving among adolescent gamblers? Psychometric properties of the Gambling Craving Scale. | Donati MA et al. | โ | 2024 | โ |
| Integrated Multidisciplinary Care Model to Manage the Dual Pathology of Alcohol Use Disorder and of Liver Disease. | Singal AK et al. | โ | 2024 | โ |
| In the balance: No new diagnosis needed in addition to opioid use disorder to study harms associated with long-term opioid therapy. | Drexler K et al. | โ | 2024 | โ |
| Learnings from a prison-based drug treatment program on planning for release: A qualitative study. | D'Souza B et al. | โ | 2024 | โ |
| Longitudinal Associations between Homelessness and Substance Use: Investigating Demographic Differences for Young Adults in Treatment. | DiGuiseppi GT et al. | โ | 2024 | โ |
| Mental and Physical Health-Related Cannabis Motives Mediate the Relationship between Childhood Trauma and Problematic Cannabis Use over Time among Emerging Adult Cannabis Users. | Conn BM et al. | โ | 2024 | โ |
| Molecular and structural insights into the 5-HT<sub>2C</sub> receptor as a therapeutic target for substance use disorders. | Ubhayarathna M et al. | โ | 2024 | โ |
| Narrative identity in addictive disorders: a conceptual review. | Deriu V et al. | โ | 2024 | โ |
| Network analysis of DSM-5 criteria for gambling disorder: considering sex differences in a large clinical sample. | Lucas I et al. | โ | 2024 | โ |
| Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids. | Miller EA et al. | โ | 2024 | โ |
| Patient perspectives on current and potential therapies and clinical trial approaches for cocaine use disorder. | Maahs S et al. | โ | 2024 | โ |
| Perceived Risks and Benefits and Frequency of Cannabis Use Among People with HIV in Different Legal Environments. | Laper S et al. | โ | 2024 | โ |
| Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study. | Rodrรญguez de Fonseca F et al. | โ | 2024 | โ |
| Predictors of treatment outcome for individuals with alcohol use disorder with a goal of controlled drinking. | Ingesson-Hammarberg S et al. | โ | 2024 | โ |
| Prenatal opioid exposure significantly impacts placental protein kinase C (PKC) and drug transporters, leading to drug resistance and neonatal opioid withdrawal syndrome. | Radhakrishna U et al. | โ | 2024 | โ |
| Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States. | Han B et al. | โ | 2024 | โ |
| Prevalence and characteristics of participants in <i>Dry January</i> 2024: findings from a general population survey in France. | Lespine LF et al. | โ | 2024 | โ |
| Psychometric properties of the modified Drug Abuse Screening Test Sinhala version (DAST-SL): evaluation of reliability and validity in Sri Lanka. | Nawaratne SD et al. | โ | 2024 | โ |
| Psychometric validation of the Diagnostic Assessment Research Tool: Alcohol use disorder module. | Garber ML et al. | โ | 2024 | โ |
| Psychotherapies in opioid use disorder: toward a step-care model. | Durpoix A et al. | โ | 2024 | โ |
| Punishment-resistant alcohol intake is mediated by the nucleus accumbens shell in female rats. | McDonald AJ et al. | โ | 2024 | โ |
| Real-time fMRI-based neurofeedback to restore brain function in substance use disorders: A systematic review of the literature. | Murphy E et al. | โ | 2024 | โ |
| Recovery from alcohol use disorder: Reinforcer pathology theory, measurement, and methods. | Bickel WK et al. | โ | 2024 | โ |
| Reflective and non-reflective influences on cannabis use among undergraduate students: A qualitative study. | Porche S et al. | โ | 2024 | โ |
| Research landscape analysis on dual diagnosis of substance use and mental health disorders: key contributors, research hotspots, and emerging research topics. | Sweileh WM | โ | 2024 | โ |
| Rethinking cutoff values for the South Oaksย Gambling Screen: Sex-specific insights andย DSM-5 severity adjustments in Gambling Disorder assessment. | Lucas I et al. | โ | 2024 | โ |
| Should we promote alcohol problems as a continuum? Implications for policy and practice. | Morris J et al. | โ | 2024 | โ |
| Smartphone use and well-being of adolescent girls: a population-based study. | Kosola S et al. | โ | 2024 | โ |
| Sociodemographic and patient reported outcomes by racial and ethnicity status among participants in a randomized controlled trial for methamphetamine use disorder. | Okafor CN et al. | โ | 2024 | โ |
| Stimulant Drugs and Stimulant Use Disorder. | Song W et al. | โ | 2024 | โ |
| Substance abuse among new patients attending main government hospitals in Malaysia from 2018-2021: A comparison between before and during COVID-19 pandemic. | Muhamad NA et al. | โ | 2024 | โ |
| Substance Use and Educational Impacts in Youth With and Without Chronic Illness. | Weitzman ER et al. | โ | 2024 | โ |
| Substance Use Disorders. | Kalin NH | โ | 2024 | โ |
| Substance Use Disorders: Population Prevention. | โ | โ | 2024 | โ |
| Substance Use Epidemiology as a Foundation for Prevention. | Lopez MF et al. | โ | 2024 | โ |
| Systematic review of patient contribution to the development of alcohol craving measurements. | Zeganadin L et al. | โ | 2024 | โ |
| The Association between Post-Traumatic Stress Disorder and Problematic Alcohol and Cannabis Use in a Multi-Ethnic Cohort in The Netherlands: The HELIUS Study. | Kรผhner C et al. | โ | 2024 | โ |
| The borderline effect for diabetes: when no difference makes a difference. | Aungle P et al. | โ | 2024 | โ |
| The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropionโ+โvarenicline in rats. | Olsson Y et al. | โ | 2024 | โ |
| The interdependence of substance use, satisfaction with life, and psychological distress: a dynamic structural equation model analysis. | Moe FD et al. | โ | 2024 | โ |
| The phenotype of recovery XI: associations of sleep quality and perceived stress with discounting and quality of life in substance use recovery. | Yeh YH et al. | โ | 2024 | โ |
| Three Contrasting Accounts of Electronic Gambling Machine Related Harm: Impacts on Community Views Towards Gambling Policy and Responsibility. | Myles D et al. | โ | 2024 | โ |
| Tolerance, interdose withdrawal symptoms, and craving predict prescription opioid-use disorder severity in chronic pain patients: A three-wave prospective study. | Rodrรญguez-Espinosa S et al. | โ | 2024 | โ |
| Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder. | Mojtabai R et al. | โ | 2024 | โ |
| Transcranial magnetic stimulation for the rehabilitation of patients with addiction: current status and future prospects. | Tang VM et al. | โ | 2024 | โ |
| Understanding alcohol use and alcohol use disorders from a developmental psychopathology perspective: Research advances, challenges, and future directions. | Chassin L et al. | โ | 2024 | โ |
| Updated guidelines for prescribing opioids to treat patients with chronic non-cancer pain in Korea: developed by committee on hospice and palliative care of the Korean Pain Society. | Kim M et al. | โ | 2024 | โ |
| Validation of drug-nondrug choice procedure to model maladaptive behavioural allocation to opioid use in rats. | Azizzadeh S et al. | โ | 2024 | โ |
| Variation in Use of Medications for Opioid Use Disorder in Critically Ill Patients Across the United States. | Feeney ME et al. | โ | 2024 | โ |
| Addiction: A treatise from 1561. | Nadeau L et al. | โ | 2023 | โ |
| Alcohol use disorder conceptualizations and diagnoses reflect their sociopolitical context. | Boness CL et al. | โ | 2023 | โ |
| Alcohol use disorder criteria exhibit different comorbidity patterns. | Watts AL et al. | โ | 2023 | โ |
| A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care. | Adeniran E et al. | โ | 2023 | โ |
| Assessing cardiac safety among clients receiving methadone as part of opioid agonist maintenance therapy (OAMT) in Durban, South Africa. | Prakaschandra DR et al. | โ | 2023 | โ |
| Assessing sugar-sweetened beverage consumption in early pregnancy using a substance abuse framework. | Ker CR et al. | โ | 2023 | โ |
| Assessing the diagnostic utility of the Cannabis Use Disorder Identification Test - Revised (CUDIT-R) among veterans with medical and non-medical cannabis use. | Myers MG et al. | โ | 2023 | โ |
| Associations of the P300 Event-Related Potentials and Self-Reported Craving in Substance Use Disorders: A Systematic Review. | Epp T et al. | โ | 2023 | โ |
| At the Crossroads between Eating Disorders and Body Dysmorphic Disorders-The Case of Bigorexia Nervosa. | Vasiliu O | โ | 2023 | โ |
| Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks. | Ang SP et al. | โ | 2023 | โ |
| Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: insights from a national self-report survey. | Slawek DE et al. | โ | 2023 | โ |
| Can severity of substance use be measured across drug classes? Estimating differential item functioning by drug class in two general measures of substance use severity. | Janulis P et al. | โ | 2023 | โ |
| Changes over time in endorsement of 11 DSM-IV alcohol use disorder (AUD) criteria in young adults with persistent or recurrent AUD in The Collaborative Study on the Genetics of Alcoholism. | Schuckit MA et al. | โ | 2023 | โ |
| Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study. | Hasin DS et al. | โ | 2023 | โ |
| Clinical Differences of mild, Moderate, and Severe Gambling Disorder in a Sample of Treatment Seeking Pathological Gamblers in Sweden. | Mide M et al. | โ | 2023 | โ |
| Comparing self-report and parental report of psychopathologies in adolescents with substance use disorders. | Kuitunen-Paul S et al. | โ | 2023 | โ |
| Comparison of binge-eating disorder and food addiction. | Ratkoviฤ D et al. | โ | 2023 | โ |
| Connectome-based predictive modelling can predict follow-up craving after abstinence in individuals with opioid use disorders. | Yang W et al. | โ | 2023 | โ |
| Contextual decision-making and alcohol use disorder criteria: Delayed reward, delayed loss, and probabilistic reward discounting. | Acuff SF et al. | โ | 2023 | โ |
| Co-occurrence of food addiction, obesity, problematic substance use, and parental history of problematic alcohol use. | Hoover LV et al. | โ | 2023 | โ |
| Craving in gambling disorder: A systematic review. | Mallorquรญ-Baguรฉ N et al. | โ | 2023 | โ |
| Digital Biomarker Applications Across the Spectrum of Opioid Use Disorder. | Rigatti M et al. | โ | 2023 | โ |
| Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. | Shmulewitz D et al. | โ | 2023 | โ |
| Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. | Chapron SA et al. | โ | 2023 | โ |
| Editorial: What is addictive in gambling? Nine years after the gambling disorder diagnosis: Does gambling fit among the addictions? | Nilsson A et al. | โ | 2023 | โ |
| Edmonton Classification System for Cancer Pain: Comparison of Pain Classification Features and Pain Intensity across Diverse Palliative Care Settings in Canada. | Belayneh M et al. | โ | 2023 | โ |
| Effects of exercise of different intensities on withdrawal symptoms among people with substance use disorder: a systematic review and meta-analysis. | Li H et al. | โ | 2023 | โ |
| Features of Addiction in Binge-Eating Disorder: Considerations for Screening and Treatment. | Paul A et al. | โ | 2023 | โ |
| Food addiction, hormones and blood biomarkers in humans: A systematic literature review. | Rรถmer SS et al. | โ | 2023 | โ |
| Free-access intravenous alcohol self-administration in social drinkers and individuals with alcohol use disorder: Evaluation of relationships with phosphatidylethanol and self-reported alcohol consumption. | Olsson Y et al. | โ | 2023 | โ |
| Ghrelin receptor antagonist JMV2959 blunts cocaine and oxycodone drug-seeking, but not self-administration, in male rats. | Merritt CR et al. | โ | 2023 | โ |
| Grounding alcohol simulation models in empirical and theoretical alcohol research: a model for a Northern Plains population in the United States. | Deutsch AR et al. | โ | 2023 | โ |
| Heterogeneity In Women's Trauma Histories: Impact On Substance Use Disorder Severity. | Gallagher C et al. | โ | 2023 | โ |
| Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia. | Bovell-Ammon BJ et al. | โ | 2023 | โ |
| Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019. | Mannes ZL et al. | โ | 2023 | โ |
| Integrated Care Models: HIV and Substance Use. | Hill K et al. | โ | 2023 | โ |
| Is sexual craving a sign of sex addiction? | Franken IHA | โ | 2023 | โ |
| Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. | Lesko CR et al. | โ | 2023 | โ |
| Management practice and discharge outcome of patients with psychiatric disorder admitted to psychiatry wards of selected specialized settings in Ethiopia. | Semman MF et al. | โ | 2023 | โ |
| Melitracen and flupentixol (deanxit) use disorder in Lebanon. | El Zahran T et al. | โ | 2023 | โ |
| Meta-review on the efficacy of psychological therapies for the treatment of substance use disorders. | Dellazizzo L et al. | โ | 2023 | โ |
| miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review. | Occhipinti C et al. | โ | 2023 | โ |
| Neuroaffective reactivity profiles are associated with vulnerability to e-cigarette use. | Versace F et al. | โ | 2023 | โ |
| Neuroimaging in Adolescents: Post-Traumatic Stress Disorder and Risk for Substance Use Disorders. | Etami Y et al. | โ | 2023 | โ |
| New approaches to deep phenotyping in addictions. | Watts AL et al. | โ | 2023 | โ |
| Non-medical use of baclofen: A case series and review of the literature. | Pelerin JM et al. | โ | 2023 | โ |
| On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol. | Niemis W et al. | โ | 2023 | โ |
| Operational definitions and measurement of externalizing behavior problems: An integrative review including research models and clinical diagnostic systems. | Torres-Rosado L et al. | โ | 2023 | โ |
| Oxytocin receptors mediate oxytocin potentiation of methylphenidate-induced stimulation of accumbens dopamine in rats. | Hersey M et al. | โ | 2023 | โ |
| Pathways to the persistence of drug use despite its adverse consequences. | McNally GP et al. | โ | 2023 | โ |
| Patterns of problematic cannabis use in Canada pre- and post-legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity. | Fataar F et al. | โ | 2023 | โ |
| People who inject oral morphine favor experimentation with injectable opioid substitution. | Bertin C et al. | โ | 2023 | โ |
| Personality Traits Associated with the Risk of Exercise Dependence in Ultraendurance Athletes: A Cross-Sectional Study. | Remilly M et al. | โ | 2023 | โ |
| Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons. | Radhakrishna U et al. | โ | 2023 | โ |
| Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome. | Radhakrishna U et al. | โ | 2023 | โ |
| Predictors of symptom course in alcohol use disorder. | Conlin WE et al. | โ | 2023 | โ |
| Proportion of Non-Medical Opioid Use of Prescription Opioids among Cancer Patients in Korea. | Go SI et al. | โ | 2023 | โ |
| Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care. | Matson TE et al. | โ | 2023 | โ |
| Psychosocial Life Aspects among Substance Misuse Clients who are at Rehabilitation Phase: A Narrative Review. | Alsubaie S | โ | 2023 | โ |
| Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation. | Jiang W et al. | โ | 2023 | โ |
| Restoring the firing activity of ventral tegmental area neurons by lateral hypothalamic deep brain stimulation following morphine administration in rats. | Nikbakhtzadeh M et al. | โ | 2023 | โ |
| Role of Microglia in Psychostimulant Addiction. | da Silva MCM et al. | โ | 2023 | โ |
| Sex differences in the clinical manifestations related to dependence behaviors in medication-overuse headache. | Wang YF et al. | โ | 2023 | โ |
| State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019. | Hasin DS et al. | โ | 2023 | โ |
| Stigmatization of people with addiction by health professionals: Current knowledge. A scoping review. | Cazalis A et al. | โ | 2023 | โ |
| Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. | Volkow ND et al. | โ | 2023 | โ |
| Substance Use Disorders and HIV/AIDS Risk Behaviors in Youth After Juvenile Detention: A 16-Year Longitudinal Study. | Stokes ML et al. | โ | 2023 | โ |
| Successful management of suspected propofol dependence with phenobarbital in an adult patient with COVID-19. | Feeney ME et al. | โ | 2023 | โ |
| Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse. | Dognin N et al. | โ | 2023 | โ |
| Susceptibility to interference between Pavlovian and instrumental control predisposes risky alcohol use developmental trajectory from ages 18 to 24. | Chen H et al. | โ | 2023 | โ |
| Techniques for Measurement of Serotonin: Implications in Neuropsychiatric Disorders and Advances in Absolute Value Recording Methods. | Rojas Cabrera JM et al. | โ | 2023 | โ |
| The Associations between Remission Status, Discounting Rates, andย Recovery from Substance Use Disorders. | Athamneh LN et al. | โ | 2023 | โ |
| The centrality of craving in network analysis of five substance use disorders. | Gauld C et al. | โ | 2023 | โ |
| The Craving-Manager smartphone app designed to diagnose substance use/addictive disorders, and manage craving and individual predictors of relapse: a study protocol for a multicenter randomized controlled trial. | Serre F et al. | โ | 2023 | โ |
| The Genetically Informed Neurobiology of Addiction (GINA) model. | Bogdan R et al. | โ | 2023 | โ |
| The Heterogeneous Nature of Substance Use and Substance Use Disorders: Implications for Characterizing Substance-Related Stigma. | Sher KJ | โ | 2023 | โ |
| The importance of translationally evaluating steroid hormone contributions to substance use. | Maher EE et al. | โ | 2023 | โ |
| The Indispensable Nasal Decongestant: Patients' Views and Perspectives on Nasal Decongestant Overuse. | Scheire S et al. | โ | 2023 | โ |
| Toward a Psychological Model of Chemical Coping with Opioids in Cancer Care. | Yusufov M et al. | โ | 2023 | โ |
| Towards neuromarkers for tailored smoking cessation treatments. | Versace F et al. | โ | 2023 | โ |
| Trends in Cannabis-positive Urine Toxicology Test Results: US Veterans Health Administration Emergency Department Patients, 2008 to 2019. | Fink DS et al. | โ | 2023 | โ |
| Underage E-Cigarette Purchasing and Vaping Progression Among Young Adults. | Harlow AF et al. | โ | 2023 | โ |
| Using a Harm Reduction Approach to Treat Inpatients With Substance Use Disorders. | Shields LBE et al. | โ | 2023 | โ |
| Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non-Clinicians. | Di Paola A et al. | โ | 2023 | โ |
| Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids). | Shmulewitz D et al. | โ | 2023 | โ |
| Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes. | Powell VD et al. | โ | 2023 | โ |
| Why Do Adolescents Relapse? A Multicenter, Cross-sectional Study. | Kardaล ร et al. | โ | 2023 | โ |
| ฮผ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges. | Salinsky LM et al. | โ | 2023 | โ |
| Abuse/Misuse of Prescription Medications in Older Adults. | Ates Bulut E et al. | โ | 2022 | โ |
| ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder. | Marino RT et al. | โ | 2022 | โ |
| A Comprehensive Model for Gambling Behaviors: Assessment of the Factors that can Contribute to the Vulnerability and Maintenance of Gambling Disorder. | Gori A et al. | โ | 2022 | โ |
| Adapting narrative exposure therapy with a tribal community: A community-based approach. | Bedard-Gilligan M et al. | โ | 2022 | โ |
| Adolescent Substance Use Disorders. | Simon KM et al. | โ | 2022 | โ |
| Altered Resting-State Network in Adolescents with Problematic Internet Use. | Siste K et al. | โ | 2022 | โ |
| Analyzing the Impact of Mobile App Engagement on Mental Health Outcomes: Secondary Analysis of the Unwinding Anxiety Program. | Nardi W et al. | โ | 2022 | โ |
| A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder. | Jones JD et al. | โ | 2022 | โ |
| A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine. | Ma L et al. | โ | 2022 | โ |
| Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment. | Haque LY et al. | โ | 2022 | โ |
| Association Between Functional and Structural Brain Connectivity of the Default Mode Network in Non-treatment Seeking Individuals With Alcohol Use Disorder. | Gerhardt S et al. | โ | 2022 | โ |
| Association of Cannabis Use-Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001-2002 and 2012-2013. | Livne O et al. | โ | 2022 | โ |
| Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the <i>DRD2</i> Gene with Neuroticism in Patients with Substance Use Disorder. | Boroล A et al. | โ | 2022 | โ |
| Automated Digital Interventions and Smoking Cessation: Systematic Review and Meta-analysis Relating Efficiency to a Psychological Theory of Intervention Perspective. | Sha L et al. | โ | 2022 | โ |
| Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses. | Butelman ER et al. | โ | 2022 | โ |
| Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial. | McAnulty C et al. | โ | 2022 | โ |
| Cannabis Use and Misuse in Older Adults. | Khoury R et al. | โ | 2022 | โ |
| Caution Is Necessary When Estimating Treatment Need for Opioid Use Disorder Using National Surveys. | Nesoff ED et al. | โ | 2022 | โ |
| Certificate-of-need laws and substance use treatment. | Bailey J et al. | โ | 2022 | โ |
| Challenges in Perinatal Drug Testing. | Kurtz T et al. | โ | 2022 | โ |
| Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017. | Zygmunt A et al. | โ | 2022 | โ |
| Clinical Outcomes of Severe Forms of Early Social Stress. | Berhe O et al. | โ | 2022 | โ |
| Coffee and cigarettes: Modulation of high and low sensitivity ฮฑ4ฮฒ2 nicotinic acetylcholine receptors by n-MP, a biomarker of coffee consumption. | Papke RL et al. | โ | 2022 | โ |
| Commercial Sexual Exploitation During Adolescence: A US-Based National Study of Adolescent to Adult Health. | Barnert ES et al. | โ | 2022 | โ |
| Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. | Fink DS et al. | โ | 2022 | โ |
| Consumer Knowledge of Insurance Coverage of Alcohol Treatment Services in the United States: Changes Since 2015. | Subbaraman MS et al. | โ | 2022 | โ |
| Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems? | Tarantino G et al. | โ | 2022 | โ |
| Dealing With the Epidemic of Endocarditis in People Who Inject Drugs. | Vervoort D et al. | โ | 2022 | โ |
| Development of a computerized adaptive substance use disorder scale for screening, measurement and diagnosis - The CAT-SUD-E. | Hulvershorn LA et al. | โ | 2022 | โ |
| Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain. | Hasin DS et al. | โ | 2022 | โ |
| Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review. | Yucel E et al. | โ | 2022 | โ |
| Differences in the Prevalence and Profile of DSM-IV and DSM-5 Alcohol Use Disorders-Results from the Singapore Mental Health Study 2016. | Subramaniam M et al. | โ | 2022 | โ |
| Differential Experience of Interdose Withdrawal During Long-Term Opioid Therapy and its Association With Patient and Treatment Characteristics: A Latent Class Analysis in Chronic Pain Population. | Rodrรญguez-Espinosa S et al. | โ | 2022 | โ |
| Drugs age-of-onset as a signal of later post-traumatic stress disorder: Bayesian analysis of a census protocol. | Santos LL et al. | โ | 2022 | โ |
| Dynamics and correlations in multiplex immune profiling reveal persistent immune inflammation in male drug users after withdrawal. | Re GF et al. | โ | 2022 | โ |
| Effects of <i>DSM-5</i> Betel-Quid-Related Symptoms, Pathological Behaviors, and Use Disorder on Oral Squamous Cell Carcinoma Risk. | Wang WC et al. | โ | 2022 | โ |
| Examining perceived effects of same-sex marriage legalization among sexual minority women: Identifying demographic differences and factors related to alcohol use disorder, depression, and self-perceived health. | Drabble LA et al. | โ | 2022 | โ |
| GABRB2, a key player in neuropsychiatric disorders and beyond. | Barki M et al. | โ | 2022 | โ |
| Heavy Burden of Toxic Dilated Cardiomyopathy Among Young Adults: A Retrospective Study and Review of the Literature. | Cinq-Mars A et al. | โ | 2022 | โ |
| How drug cravings affect metacognitive monitoring in methamphetamine abusers. | Liu Y et al. | โ | 2022 | โ |
| Illicit Drug Use and Smell and Taste Dysfunction: A National Health and Nutrition Examination Survey 2013-2014. | Kao HH et al. | โ | 2022 | โ |
| Illicit Drug Use in Older Adults: An Invisible Epidemic? | Ghantous Z et al. | โ | 2022 | โ |
| Impact of Substance Use Disorder on Between-Network Brain Connectivity in Early Psychosis. | Chan SY et al. | โ | 2022 | โ |
| Increased responsiveness to punishment of cocaine self-administration after experience with high punishment. | Durand A et al. | โ | 2022 | โ |
| Insufficient Physical Activity Is a Global Marker of Severity in Alcohol Use Disorder: Results from a Cross-Sectional Study in 382 Treatment-Seeking Patients. | Ternay J et al. | โ | 2022 | โ |
| Intersectional stigma subgroup differences in unhealthy drinking and disordered marijuana use among Black and Latino cisgender sexual minority young men. | Layland EK et al. | โ | 2022 | โ |
| Investigating the circulating sphingolipidome response to a single high-intensity interval training session within healthy females and males in their twenties (SphingoHIIT): Protocol for a randomised controlled trial. | Carrard J et al. | โ | 2022 | โ |
| Klerman's "credo" reconsidered: neo-Kraepelinianism, Spitzer's views, and what we can learn from the past. | Wakefield JC | โ | 2022 | โ |
| Leveraging Accelerometry as a Prognostic Indicator for Increase in Opioid Withdrawal Symptoms. | Lambert TP et al. | โ | 2022 | โ |
| Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience. | Strickland JC et al. | โ | 2022 | โ |
| Mental health-related quality of life by sex and sexual identity among U.S. adults with alcohol and tobacco use disorder. | Evans-Polce RJ et al. | โ | 2022 | โ |
| Molecular genetics of cocaine use disorders in humans. | Fernร ndez-Castillo N et al. | โ | 2022 | โ |
| Moral Injury in the Context of Substance Use Disorders: a Narrative Review. | Van Denend J et al. | โ | 2022 | โ |
| More than Addiction-The Nucleus Accumbens Contribution to Development of Mental Disorders and Neurodegenerative Diseases. | Bayassi-Jakowicka M et al. | โ | 2022 | โ |
| Neural cue reactivity is not stronger in male than in female patients with alcohol use disorder. | Gerhardt S et al. | โ | 2022 | โ |
| Neuroaffective profiles are associated with e-cigarette use | Versace F et al. | โ | 2022 | โ |
| Neurobiological mechanisms and related clinical treatment of addiction: a review. | Fang Y et al. | โ | 2022 | โ |
| Neurodevelopmental origins of substance use disorders: Evidence from animal models of early-life adversity and addiction. | Levis SC et al. | โ | 2022 | โ |
| Opioid safety recommendations in adult palliative medicine: a North American Delphi expert consensus. | Lau J et al. | โ | 2022 | โ |
| Opioid Use Disorder and Racial/Ethnicย Health Disparities: Prevention and Management. | Siddiqui N et al. | โ | 2022 | โ |
| Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Enkema MC et al. | โ | 2022 | โ |
| Paroxysmal Sustained Ventricular Tachycardia with Cardiac Arrest and Myocardial Infarction in 29-Year-Old Man Addicted to Medical Marijuana-It Never Rains but It Pours. | Wiliลski J et al. | โ | 2022 | โ |
| Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex. | Garcรญa-Marchena N et al. | โ | 2022 | โ |
| Post-Combat-Injury Opioid Prescription and Alcohol Use Disorder in the Military. | Alcover KC et al. | โ | 2022 | โ |
| Prevalence of cannabis use disorder among pregnant people who test positive for cannabis at time of delivery. | Wicken C et al. | โ | 2022 | โ |
| Psychometric evaluation of a Swedish version of the Impaired Control Scale for individuals with alcohol use disorder. | Ingesson S et al. | โ | 2022 | โ |
| Psychometric evaluation of the treatment entry questionnaire to assess extrinsic motivation for inpatient addiction treatment. | Walji A et al. | โ | 2022 | โ |
| Relentless Stigma: A Qualitative Analysis of a Substance Use Recovery Needs Assessment. | Medina S et al. | โ | 2022 | โ |
| Reliability of Differential Item Functioning in Alcohol Use Disorder: Bayesian Meta-Analysis of Criteria Discrimination Estimates. | Vize CE et al. | โ | 2022 | โ |
| Roles and Effects of Peer Recovery Coach Intervention in the Field of Substance Abuse: An Integrative Literature Review. | Kang KI et al. | โ | 2022 | โ |
| Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis. | Patel PV et al. | โ | 2022 | โ |
| Sex Differences in Psychostimulant Abuse: Implications for Estrogen Receptors and Histone Deacetylases. | Torres OV | โ | 2022 | โ |
| Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. | Terasaki D et al. | โ | 2022 | โ |
| Spiritual Benefit from Cannabis. | Heide FJ et al. | โ | 2022 | โ |
| Substance use and common contributors to morbidity: A genetics perspective. | Sanchez-Roige S et al. | โ | 2022 | โ |
| Substance Use Disorder in Older Adults: Mini Review. | Jaqua EE et al. | โ | 2022 | โ |
| Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records. | Hasin DS et al. | โ | 2022 | โ |
| Substance use-related suicide after release from correctional, behavioral health, and healthcare facilities using national violent death reporting system data. | Mennicke A et al. | โ | 2022 | โ |
| Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges. | Tijani AO et al. | โ | 2022 | โ |
| The phenotype of recovery II: The association between delay discounting, self-reported quality of life, and remission status among individuals in recovery from substance use disorders. | Athamneh LN et al. | โ | 2022 | โ |
| Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019. | Hasin DS et al. | โ | 2022 | โ |
| Using primary care data to understand opioid prescribing, policy impacts and clinical outcomes: A protocol for the OPPICO study. | Cangadis-Douglass H et al. | โ | 2022 | โ |
| Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use. | Shmulewitz D et al. | โ | 2022 | โ |
| Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder. | Requena-Ocaรฑa N et al. | โ | 2022 | โ |
| A comparison of fraud to fund gambling with fraud for other reasons. | Dougherty E et al. | โ | 2021 | โ |
| A Concept Analysis of Dependence Using Rodgers' Evolutionary Method. | Lingerfelt CN et al. | โ | 2021 | โ |
| Activation of peroxisome proliferator-activated receptor ฮณ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats. | Fotio Y et al. | โ | 2021 | โ |
| Addiction as a brain disease revised: why it still matters, and the need for consilience. | Heilig M et al. | โ | 2021 | โ |
| Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users. | Livne O et al. | โ | 2021 | โ |
| Alcohol Seeking Under Risk of Punishment Is Associated With Activation of Cortical and Subcortical Brain Regions. | McDonald AJ et al. | โ | 2021 | โ |
| A Method for Detecting and Analyzing Facial Features of People with Drug Use Disorders. | Li Y et al. | โ | 2021 | โ |
| Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France. | Guillou-Landreat M et al. | โ | 2021 | โ |
| A Narrative Review of Third-Wave Cognitive-Behavioral Therapies in Addiction. | Balandeh E et al. | โ | 2021 | โ |
| A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department. | Wiercigroch D et al. | โ | 2021 | โ |
| A review of cross-commodity delay discounting research with relevance to addiction. | Pritschmann RK et al. | โ | 2021 | โ |
| Association between prescribed opioid use for acute pain in adolescents and the subsequent development of opioid misuse and substance use disorders: a systematic review protocol. | Rahmandar M et al. | โ | 2021 | โ |
| Association between school racial/ethnic composition during adolescence and adult health. | Dudovitz RN et al. | โ | 2021 | โ |
| Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case-control study. | Tajbakhsh A et al. | โ | 2021 | โ |
| Attitudes and beliefs about recreational cannabis legalization among cannabis-using young adults in Los Angeles: Impact on concurrent cannabis practices and problematic cannabis use. | Wong CF et al. | โ | 2021 | โ |
| Burden of cannabis use and disorder in the U.S. veteran population: Psychiatric comorbidity, suicidality, and service utilization. | Hill ML et al. | โ | 2021 | โ |
| BXD Recombinant Inbred Mice as a Model to Study Neurotoxicity. | Martins AC et al. | โ | 2021 | โ |
| Cannabis use and cannabis use disorder. | Connor JP et al. | โ | 2021 | โ |
| Clinical and psychological factors associated with interdose opioid withdrawal in chronic pain population. | Rodrรญguez-Espinosa S et al. | โ | 2021 | โ |
| Combinatorial Optimization of Clustering Decisions: An Approach to Refine Psychiatric Diagnoses. | Loeffelman JE et al. | โ | 2021 | โ |
| Commentary: Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice. | Zheng R et al. | โ | 2021 | โ |
| Community-Based Yoga for Women Undergoing Substance Use Disorder Treatment: A Descriptive Study. | Galantino ML et al. | โ | 2021 | โ |
| Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys. | Onaemo VN et al. | โ | 2021 | โ |
| Covid-19 interface with drug misuse and substance use disorders. | Cisneros IE et al. | โ | 2021 | โ |
| Craving for Ketamine and Its Relationship With Clinical Outcome Indicators in Males With Ketamine Use Disorder. | Wang PW et al. | โ | 2021 | โ |
| Delay Discounting in Established and Proposed Behavioral Addictions: A Systematic Review and Meta-Analysis. | Weinsztok S et al. | โ | 2021 | โ |
| Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre. | Kabisa E et al. | โ | 2021 | โ |
| Diagnostic Accuracy of the Drug Use Disorder Identification Test and Its Short Form, the DUDIT-C, in German Adolescent Psychiatric Patients. | Basedow LA et al. | โ | 2021 | โ |
| Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. | Kervran C et al. | โ | 2021 | โ |
| Does crude measurement contribute to observed unidimensionality of psychological constructs? A demonstration with DSM-5 alcohol use disorder. | Watts AL et al. | โ | 2021 | โ |
| Down and High: Reflections Regarding Depression and Cannabis. | Langlois C et al. | โ | 2021 | โ |
| Effects of low-dose alcohol exposure in adolescence on subsequent alcohol drinking in adulthood in a rat model of depression. | Siska F et al. | โ | 2021 | โ |
| Effects of topiramate on the association between affect, cannabis craving, and cannabis use in the daily life of youth during a randomized clinical trial. | Emery NN et al. | โ | 2021 | โ |
| Endorsement of specific alcohol use disorder criterion items changes with age in individuals with persistent alcohol use disorders in 2 generations of the San Diego Prospective Study. | Schuckit MA et al. | โ | 2021 | โ |
| Epigenetic Analyses of Alcohol Consumption in Combustible and Non-Combustible Nicotine Product Users. | Dawes K et al. | โ | 2021 | โ |
| Epigenetic Regulation of Circadian Clocks and Its Involvement in Drug Addiction. | Saad L et al. | โ | 2021 | โ |
| Evaluating sedative effects of dexmedetomidine and morphine in the patients with opioid use disorder undergoing cataract surgery. | Moradi Farsani D et al. | โ | 2021 | โ |
| Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review. | Powell VD et al. | โ | 2021 | โ |
| Examining the construct validity of food addiction severity specifiers. | Wiedemann AA et al. | โ | 2021 | โ |
| Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health. | Nagata JM et al. | โ | 2021 | โ |
| Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance. | Tambon M et al. | โ | 2021 | โ |
| Genetics of substance use disorders: a review. | Deak JD et al. | โ | 2021 | โ |
| Heterogeneity in DSM-5 Symptom Criteria: Phenotypes of Alcohol Use Disorder in a Sample Seeking Alcohol Treatment. | Zhao J et al. | โ | 2021 | โ |
| HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic. | Denis CM et al. | โ | 2021 | โ |
| How to screen for at-risk alcohol use in transplant patients? From instrument selection to implementation of the AUDIT-C. | Verhalle L et al. | โ | 2021 | โ |
| Identifying Self-Management Support Needs for Pregnant Women With Opioid Misuse in Online Health Communities: Mixed Methods Analysis of Web Posts. | Liang OS et al. | โ | 2021 | โ |
| Increased sugar-sweetened beverage use tendency in pregnancy positively associates with peripartum Edinburgh postpartum depression scores. | Ker CR et al. | โ | 2021 | โ |
| Joint perceptions of the risk and availability of Cannabis in the United States, 2002-2018. | Levy NS et al. | โ | 2021 | โ |
| Limited treatment accessibility: Implications for alcohol treatment disparities among Mexican Americans living in the U.S.-Mexico border region. | Bensley KMK et al. | โ | 2021 | โ |
| Link Between Perception of Treatment Need and Craving Reports in Addiction. | Lambert L et al. | โ | 2021 | โ |
| Low Back Pain and Substance Use: Diagnostic and Administrative Coding for Opioid Use and Dependence Increased in U.S. Older Adults with Low Back Pain. | Hogans BB et al. | โ | 2021 | โ |
| Metabolomics reveals biomarkers of opioid use disorder. | Ghanbari R et al. | โ | 2021 | โ |
| Mindfulness-based interventions for substance use disorders. | Goldberg SB et al. | โ | 2021 | โ |
| Molecular genetics of substance use disorders: An umbrella review. | Lopez-Leon S et al. | โ | 2021 | โ |
| Not all symptoms of alcohol dependence are developmentally equivalent: Implications for the false-positives problem. | Vergรฉs A et al. | โ | 2021 | โ |
| Number of opioid overdoses and depression as a predictor of suicidal thoughts. | Brown LA et al. | โ | 2021 | โ |
| Parental Monitoring, Individual Dispositions, and Alcohol Use Disorder: A Longitudinal Study with Young Swiss Men. | Sobrino-Piazza J et al. | โ | 2021 | โ |
| Pharmacology of Drugs Used as Stimulants. | Docherty JR et al. | โ | 2021 | โ |
| Phytocannabinoids Biosynthesis in Angiosperms, Fungi, and Liverworts and Their Versatile Role. | Arif Y et al. | โ | 2021 | โ |
| Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome. | Radhakrishna U et al. | โ | 2021 | โ |
| Prenatal opioid exposure and vulnerability to future substance use disorders in offspring. | Abu Y et al. | โ | 2021 | โ |
| Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease. | Carney H et al. | โ | 2021 | โ |
| Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis. | Kowalec K et al. | โ | 2021 | โ |
| Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults. | Gutkind S et al. | โ | 2021 | โ |
| Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. | Blum K et al. | โ | 2021 | โ |
| Randomized controlled trial of twelve-step volunteer linkage for women with alcohol use disorder leaving jail. | Johnson JE et al. | โ | 2021 | โ |
| Recommended Use of Terminology in Addiction Medicine. | Saitz R et al. | โ | 2021 | โ |
| Reliability and validity of physical fitness tests in people with mental disorders: A systematic review and meta-analysis. | de Oliveira Tavares VD et al. | โ | 2021 | โ |
| Role of Neonatal Biomarkers of Exposure to Psychoactive Substances to Identify Maternal Socio-Demographic Determinants. | Jarque P et al. | โ | 2021 | โ |
| Self-Injury Is My Drug: The Functions of Describing Nonsuicidal Self-Injury as an Addiction. | Pritchard TR et al. | โ | 2021 | โ |
| Sleep deficits and cannabis use behaviors: an analysis of shared genetics using linkage disequilibrium score regression and polygenic risk prediction. | Winiger EA et al. | โ | 2021 | โ |
| Smoking Beyond Prison Bans: The Impact of Prison Tobacco Bans on Smoking Among Prison Entrants. | Albany H et al. | โ | 2021 | โ |
| Sodium Chloride, Migraine and Salt Withdrawal: Controversy and Insights. | Brown RB | โ | 2021 | โ |
| Substance Use, Gambling, Binge-Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies. | Carr MM et al. | โ | 2021 | โ |
| Symptom networks in patients with substance use disorders. | Rutten RJT et al. | โ | 2021 | โ |
| Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)-efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up. | Henrik G et al. | โ | 2021 | โ |
| The Etiologic, Theory-Based, Ontogenetic Hierarchical Framework of Alcohol Use Disorder: A Translational Systematic Review of Reviews. | Boness CL et al. | โ | 2021 | โ |
| The IntelliCage System: A Review of Its Utility as a Novel Behavioral Platform for a Rodent Model of Substance Use Disorder. | Iman IN et al. | โ | 2021 | โ |
| The profound heterogeneity of substance use disorders: Implications for treatment development. | Carroll KM | โ | 2021 | โ |
| The transition time to gambling disorder: The roles that age, gambling preference and personality traits play. | Pettorruso M et al. | โ | 2021 | โ |
| The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013. | Shmulewitz D et al. | โ | 2021 | โ |
| Urban upbringing and psychiatric disorders in the United States: A racial comparison. | Oh H et al. | โ | 2021 | โ |
| What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report. | Guillou-Landreat M et al. | โ | 2021 | โ |
| Which came first: Cannabis use or deficits in impulse control? | Rinehart L et al. | โ | 2021 | โ |
| [Which indications for inpatient admission of a patient with an addiction? Application of the chronic disorders model. A face validity study]. | Boisrobert S et al. | โ | 2021 | โ |
| Adenosine A<sub>2A</sub>Receptors in Substance Use Disorders: A Focus on Cocaine. | Wydra K et al. | โ | 2020 | โ |
| Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence. | Lorenzetti V et al. | โ | 2020 | โ |
| Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder. | Haass-Koffler CL et al. | โ | 2020 | โ |
| Analysis of substance use and its outcomes by machine learning: II. Derivation and prediction of the trajectory of substance use severity. | Hu Z et al. | โ | 2020 | โ |
| A randomized comparison trial of culturally adapted HIV prevention approaches for Native Americans reducing trauma symptoms versus substance misuse: The Healing Seasons protocol. | Pearson CR et al. | โ | 2020 | โ |
| A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use. | Wiercigroch D et al. | โ | 2020 | โ |
| Australia's Gambling Epidemic: The Role of Neighbourhood Ethnic Diversity. | Awaworyi Churchill S et al. | โ | 2020 | โ |
| Biomarkers and neuromodulation techniques in substance use disorders. | Habelt B et al. | โ | 2020 | โ |
| CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions. | Brown KG et al. | โ | 2020 | โ |
| Changes in DSM criteria following a culturally-adapted computerized CBT for Spanish-speaking individuals with substance use disorders. | Silva MA et al. | โ | 2020 | โ |
| "Chasing the first high": memory sampling in drug choice. | Bornstein AM et al. | โ | 2020 | โ |
| Cholinergic Receptors and Addiction. | Papke RL et al. | โ | 2020 | โ |
| Clinical and biobehavioral perspectives: Is medication overuse headache a behavior of dependence? | Lau CI et al. | โ | 2020 | โ |
| Common substance use disorders in older adults. | Seim L et al. | โ | 2020 | โ |
| Continuum beliefs are associated with higher problem recognition than binary beliefs among harmful drinkers without addiction experience. | Morris J et al. | โ | 2020 | โ |
| Craving mediates the effect of impulsivity on lapse-risk during alcohol use disorder treatment. | Coates JM et al. | โ | 2020 | โ |
| Development and Validation of the Recognizing Addictive Disorders Scale: A Transdiagnostic Measure of Substance-Related and Other Addictive Disorders. | Carr MM et al. | โ | 2020 | โ |
| Diagnostic inflation in the DSM: A meta-analysis of changes in the stringency of psychiatric diagnosis from DSM-III to DSM-5. | Fabiano F et al. | โ | 2020 | โ |
| Distress Tolerance as a Familial Vulnerability for Distress-Misery Disorders. | Macatee RJ et al. | โ | 2020 | โ |
| Drug Use Disorders and Violence: Associations With Individual Drug Categories. | Zhong S et al. | โ | 2020 | โ |
| Epidemiology of Alcohol Misuse and Illicit Drug Use Among Young People Aged 15-24 Years in Fishing Communities in Uganda. | Kuteesa MO et al. | โ | 2020 | โ |
| Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study. | Mohammed SA et al. | โ | 2020 | โ |
| Genome-Wide Association Study of Opioid Cessation. | Cox JW et al. | โ | 2020 | โ |
| Greater delay discounting and cannabis coping motives are associated with more frequent cannabis use in a large sample of adult cannabis users. | Sofis MJ et al. | โ | 2020 | โ |
| Hospitalization outcomes of people who use drugs: One size does not fit all. | Merchant E et al. | โ | 2020 | โ |
| How addicted are newly admitted undergraduate medical students to smartphones?: a cross-sectional study from Chitwan medical college, Nepal. | Karki S et al. | โ | 2020 | โ |
| Identifying an accurate self-reported screening tool for alcohol use disorder: evidence from a Swiss, male population-based assessment. | Baggio S et al. | โ | 2020 | โ |
| Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US Veterans. | Siglin J et al. | โ | 2020 | โ |
| Intergenerational marijuana use: A life course examination of the relationship between parental trajectories of marijuana use and the onset of marijuana use by offspring. | Bears Augustyn M et al. | โ | 2020 | โ |
| Intrauterine Substance Exposure and the Risk for Subsequent Physical Abuse Hospitalizations. | Puls HT et al. | โ | 2020 | โ |
| Investigating Betel Nut Use, Antecedents and Consequences: A Review of Literature. | Joo YJ et al. | โ | 2020 | โ |
| Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. | Cavicchioli M et al. | โ | 2020 | โ |
| Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special? | Kervran C et al. | โ | 2020 | โ |
| Multiple trajectories of alcohol use and the development of alcohol use disorder: Do Swiss men mature-out of problematic alcohol use during emerging adulthood? | Lemoine M et al. | โ | 2020 | โ |
| Persisting on the past: Cross-sectional and prospective associations between sunk cost propensity and cannabis use. | Sofis MJ et al. | โ | 2020 | โ |
| Psychometric validation of an adaptation of the Penn Alcohol Craving Scale to assess aggregated drug craving. | Costello MJ et al. | โ | 2020 | โ |
| Racial/ethnic discrimination and alcohol use disorder severity among United States adults. | Glass JE et al. | โ | 2020 | โ |
| Rate of opioid use disorder in adults who received prescription opioid pain therapy-A secondary data analysis. | Just JM et al. | โ | 2020 | โ |
| Reducing Risky Alcohol Use <i>via</i> Smartphone App Skills Training Among Adult Internet Help-Seekers: A Randomized Pilot Trial. | Berman AH et al. | โ | 2020 | โ |
| Regulation of GABA<sub>A</sub> Receptor Subunit Expression in Substance Use Disorders. | Barker JS et al. | โ | 2020 | โ |
| Resilience and Adverse Childhood Experiences: Associations With Poor Mental Health Among Homeless Adults. | Liu M et al. | โ | 2020 | โ |
| Review of Medicinal Use of <i>Cannabis</i> Derivatives and the Societal Impact of Legalization. | Malik A et al. | โ | 2020 | โ |
| Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms. | Sayre M et al. | โ | 2020 | โ |
| Screening for Mental Health and Substance Use Disorders in Obstetric Settings. | Byatt N et al. | โ | 2020 | โ |
| Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: Findings from a nationally representative survey of US adults (NESARC-III). | Geoffroy PA et al. | โ | 2020 | โ |
| Smartphone use and primary headache: A cross-sectional hospital-based study. | Uttarwar P et al. | โ | 2020 | โ |
| Study Protocol for Teen Inflammation Glutamate Emotion Research (TIGER). | Walker JC et al. | โ | 2020 | โ |
| Substance use disorders: diagnosis and management for hospitalists. | Pasha AK et al. | โ | 2020 | โ |
| Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis. | Haque LY et al. | โ | 2020 | โ |
| Temporal Dynamics of Large-Scale Networks Predict Neural Cue Reactivity and Cue-Induced Craving. | Wang KS et al. | โ | 2020 | โ |
| Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview. | Hasin D et al. | โ | 2020 | โ |
| The Alcohol Dependence Scale and DSM-5 alcohol use disorder: Severity ratings correspond insufficiently in older patients. | Mejldal A et al. | โ | 2020 | โ |
| The performance of DSM-5 alcohol use disorder and quantity-frequency of alcohol consumption criteria: An item response theory analysis. | Saha TD et al. | โ | 2020 | โ |
| The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. | Loflin MJE et al. | โ | 2020 | โ |
| U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013. | Hasin DS et al. | โ | 2020 | โ |
| Using Complete Enumeration to Derive "One-Size-Fits-All" Versus "Subgroup-Specific" Diagnostic Rules for Substance Use Disorder. | Boness CL et al. | โ | 2020 | โ |
| Validation of the Substance Use Risk Profile Scale in Lithuanian population. | Kaminskaite M et al. | โ | 2020 | โ |
| What Is Recovery? | Witkiewitz K et al. | โ | 2020 | โ |
| Where Do Gambling Problems Fit in the Structure of Psychopathology During Emerging Adulthood? | King SM et al. | โ | 2020 | โ |
| Absence of compulsive drinking phenotype in adult male rats exposed to ethanol in a binge-like pattern during adolescence. | Nentwig TB et al. | โ | 2019 | โ |
| A data-driven method for identifying shorter symptom criteria sets: the case for DSM-5 alcohol use disorder. | Raffo CD et al. | โ | 2019 | โ |
| Adding an orange to the banana bag: vitamin C deficiency is common in alcohol use disorders. | Marik PE et al. | โ | 2019 | โ |
| Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men. | Estรฉvez-Lamorte N et al. | โ | 2019 | โ |
| Alcohol Use Disorders in ICD-11: Past, Present, and Future. | Saunders JB et al. | โ | 2019 | โ |
| An Examination of Comorbid Psychiatric Disorders in Disordered Gamblers Versus Other Substance-Related Disorders. | Nicholson R et al. | โ | 2019 | โ |
| Animal models in addiction research: A dimensional approach. | Lamontagne SJ et al. | โ | 2019 | โ |
| Are Some Alcohol Use Disorder Criteria More (or Less) Externalizing than Others? Distinguishing Alcohol Use Symptomatology from General Externalizing Psychopathology. | McDowell YE et al. | โ | 2019 | โ |
| Associations between attention deficit hyperactivity and internet gaming disorder symptoms: Is there consistency across types of symptoms, gender and countries? | Stavropoulos V et al. | โ | 2019 | โ |
| Associations between sociodemographic characteristics and substance use disorder severity among methamphetamine-using men who have sex with men. | Anderson-Carpenter KD et al. | โ | 2019 | โ |
| Auditory mismatch detection, distraction, and attentional reorientation (MMN-P3a-RON) in neurological and psychiatric disorders: A review. | Justo-Guillรฉn E et al. | โ | 2019 | โ |
| Cannabinoids in Pain Treatment: An Overview. | Mallick-Searle T et al. | โ | 2019 | โ |
| Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016. | Santaella-Tenorio J et al. | โ | 2019 | โ |
| Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. | Compton WM et al. | โ | 2019 | โ |
| Case 6-2019: A 29-Year-Old Woman with Nausea, Vomiting, and Diarrhea. | Walley AY et al. | โ | 2019 | โ |
| Clinical Study of Restless Leg Syndrome Accompanied by Psychological Symptoms Induced by High-Dose Treatment With Madopar. | Zhu L et al. | โ | 2019 | โ |
| Cocaine-associated decision-making: Toward isolating preference. | Beckmann JS et al. | โ | 2019 | โ |
| Comparison of implant related complications amongst patients with opioid use disorder and non-users following total knee arthroplasty. | Vakharia RM et al. | โ | 2019 | โ |
| Craving and opioid use disorder: A scoping review. | Kleykamp BA et al. | โ | 2019 | โ |
| Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice. | Kakko J et al. | โ | 2019 | โ |
| Deriving alternative criteria sets for alcohol use disorders using statistical optimization: Results from the National Survey on Drug Use and Health. | Boness CL et al. | โ | 2019 | โ |
| Development of the Gambling Disorder Identification Test (G-DIT): Protocol for a Delphi Method Study. | Molander O et al. | โ | 2019 | โ |
| Drug-Induced Craving for Methamphetamine Is Associated With Neural Methamphetamine Cue Reactivity. | Grodin EN et al. | โ | 2019 | โ |
| DSM-5 Alcohol Use Disorder Severity as a Function of Sexual Orientation Discrimination: A National Study. | McCabe SE et al. | โ | 2019 | โ |
| Dying on Hospice in the Midst of an Opioid Crisis: What Should We Do Now? | Gabbard J et al. | โ | 2019 | โ |
| Effects of ketamine treatment on cocaine-induced reinstatement and disruption of functional connectivity in unanesthetized rhesus monkeys. | Maltbie EA et al. | โ | 2019 | โ |
| Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors. | Butelman ER et al. | โ | 2019 | โ |
| Evaluating the Validity of the DSM-5 Alcohol Use Disorder Diagnostic Criteria in a Sample of Treatment-seeking Native Americans. | Serier KN et al. | โ | 2019 | โ |
| Examining the relation of personality factors to substance use disorder by explanatory item response modeling of DSM-5 symptoms. | Chen F et al. | โ | 2019 | โ |
| [Gambling and Gaming disorders and physical health of players: A critical review of the literature]. | Benchebra L et al. | โ | 2019 | โ |
| ICD-11 for Alcohol Use Disorders: Not a Convincing Answer to the Challenges. | Rehm J et al. | โ | 2019 | โ |
| Impact of Substance Use Disorder on the Rate of Sustained Virological Response in Veterans With Chronic Hepatitis C Treated With Direct-Acting Antivirals. | Ottman AA et al. | โ | 2019 | โ |
| Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites. | Richards JE et al. | โ | 2019 | โ |
| Interventions to integrate care for people with serious mental illness and substance use disorders: a systematic scoping review protocol. | Richardson A et al. | โ | 2019 | โ |
| Light and heavy drinking in jurisdictions with different alcohol policy environments. | Foster S et al. | โ | 2019 | โ |
| Making measurement-based care for addictions a reality in primary care. | Bradley KA et al. | โ | 2019 | โ |
| Marijuana Consumption in Liver Transplant Recipients. | Serrano Rodriguez P et al. | โ | 2019 | โ |
| Multifaceted Quality Improvement Initiative Improves Retention in Treatment for Youth with Opioid Use Disorder. | Cottrill CB et al. | โ | 2019 | โ |
| Neurocognitive decision-making processes of casual methamphetamine users. | Droutman V et al. | โ | 2019 | โ |
| Not all alcohol use disorder criteria are equally severe: Toward severity grading of individual criteria in college drinkers. | Boness CL et al. | โ | 2019 | โ |
| Pharmacy: Addressing substance use in the 21st century. | Bratberg J | โ | 2019 | โ |
| Playing with a Stacked Deck: Literature Review and Case Series of Problem Gambling in Adults with Intellectual and Developmental Disabilities. | Scheidemantel T et al. | โ | 2019 | โ |
| Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer. | Paik SH et al. | โ | 2019 | โ |
| Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. | Udo T et al. | โ | 2019 | โ |
| Psychiatric comorbidities in alcohol use disorder. | Castillo-Carniglia A et al. | โ | 2019 | โ |
| Reduced Risk of Alcohol-Induced Pancreatitis With Cannabis Use. | Adejumo AC et al. | โ | 2019 | โ |
| Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point. | Kiluk BD et al. | โ | 2019 | โ |
| Rewiring the Addicted Brain Through a Psychobiological Model of Physical Exercise. | Costa KG et al. | โ | 2019 | โ |
| Risk factors for alcohol use among pregnant women, ages 15-44, in the United States, 2002 to 2017. | Shmulewitz D et al. | โ | 2019 | โ |
| Screen of drug use: Diagnostic accuracy for opioid use disorder. | Tiet QQ et al. | โ | 2019 | โ |
| Severity of Substance Use Disorder: Utility as an Outcome in Clinical Settings. | Dacosta-Sรกnchez D et al. | โ | 2019 | โ |
| Sexual orientation and gender identity disparities in substance use disorders during young adulthood in a United States longitudinal cohort. | Jun HJ et al. | โ | 2019 | โ |
| Smoking status and quit behaviors among health center patients with substance use disorders: A national study. | Fine DR et al. | โ | 2019 | โ |
| Social work: Addressing substance use in the 21st century. | Osborne-Leute V et al. | โ | 2019 | โ |
| Structural and Functional Alterations in Betel-Quid Chewers: A Systematic Review of Neuroimaging Findings. | Sariah A et al. | โ | 2019 | โ |
| Sub-dimensions of Alcohol Use Disorder in Alcohol Preferring and Non-preferring Rats, a Comparative Study. | Domi A et al. | โ | 2019 | โ |
| Symptoms of 'food addiction' in binge eating disorder using the Yale Food Addiction Scale version 2.0. | Carter JC et al. | โ | 2019 | โ |
| The Adjective Rating Scale for Withdrawal: Validation of its ability to assess severity of prescription opioid misuse. | Coloma-Carmona A et al. | โ | 2019 | โ |
| The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid- and cocaine-use problems in a community sample. | Stull SW et al. | โ | 2019 | โ |
| The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act. | Maclean JC et al. | โ | 2019 | โ |
| The influence of sample selection on the structure of psychopathology symptom networks: An example with alcohol use disorder. | Hoffman M et al. | โ | 2019 | โ |
| The Neuroscience of Drug Reward and Addiction. | Volkow ND et al. | โ | 2019 | โ |
| The patient with substance use disorder. | Anitescu M | โ | 2019 | โ |
| The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7โUS health systems. | Lapham GT et al. | โ | 2019 | โ |
| The role of neurocognitive functioning, substance use variables and the DSM-5 severity scale in cocaine relapse: A prospective study. | Lima DR et al. | โ | 2019 | โ |
| The United States opioid epidemic. | Lyden J et al. | โ | 2019 | โ |
| The value of harm reduction for injection drug use: A clinical and public health ethics analysis. | Vearrier L | โ | 2019 | โ |
| Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. | Hasin DS et al. | โ | 2019 | โ |
| Toward more efficient diagnostic criteria sets and rules: The use of optimization approaches in addiction science. | Stevens JE et al. | โ | 2019 | โ |
| Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016. | Wei YJ et al. | โ | 2019 | โ |
| What Is Addiction? How Can Animal and Human Research Be Used to Advance Research, Diagnosis, and Treatment of Alcohol and Other Substance Use Disorders? | Bickel WK et al. | โ | 2019 | โ |
| Withdrawal symptoms predict prescription opioid dependence in chronic pain patients. | Coloma-Carmona A et al. | โ | 2019 | โ |
| Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters? | Salwan AJ et al. | โ | 2018 | โ |
| Addiction to death. | Reisinger M | โ | 2018 | โ |
| A little rein on addiction. | Mathuru AS | โ | 2018 | โ |
| ANCO-GeneDB: annotations and comprehensive analysis of candidate genes for alcohol, nicotine, cocaine and opioid dependence. | Hu R et al. | โ | 2018 | โ |
| Association of DSM-5 Betel-Quid Use Disorder With Oral Potentially Malignant Disorder in 6 Betel-Quid Endemic Asian Populations. | Lee CH et al. | โ | 2018 | โ |
| Baclofen for alcohol use disorder. | Minozzi S et al. | โ | 2018 | โ |
| Balancing validity, utility and public health considerations in disorders due to addictive behaviours. | Stein DJ et al. | โ | 2018 | โ |
| Behavioral Addictions as Mental Disorders: To Be or Not To Be? | Petry NM et al. | โ | 2018 | โ |
| Caffeine use disorder: An item-response theory analysis of proposed DSM-5 criteria. | รgoston C et al. | โ | 2018 | โ |
| Cannabinoids and Pain: New Insights From Old Molecules. | Vuฤkoviฤ S et al. | โ | 2018 | โ |
| Cervical dystonia and substance abuse. | Mahajan A et al. | โ | 2018 | โ |
| Change in DSM-5 Alcohol Use Disorder Criteria Count and Severity Level as a Treatment Outcome Indicator: Results from a Randomized Trial. | Kiluk BD et al. | โ | 2018 | โ |
| Changes in prevalence and correlates of alcohol-use disorders in Finland in an 11-year follow-up. | Peรฑa S et al. | โ | 2018 | โ |
| Characterizing Anxiety Among Individuals Receiving Treatment for Alcohol and Substance Use Disorders. | Domenico LH et al. | โ | 2018 | โ |
| Chinese adaptation of the Ten-Item Internet Gaming Disorder Test and prevalence estimate of Internet gaming disorder among adolescents in Taiwan. | Chiu YC et al. | โ | 2018 | โ |
| [Consultation/liaison addiction medicine: Tools and specificities]. | Polomรฉni P et al. | โ | 2018 | โ |
| Craving as a DSM-5 Symptom of Alcohol Use Disorder in Non-Treatment Seekers. | Hartwell EE et al. | โ | 2018 | โ |
| Craving Behavior from Opioid Addiction Controlled with Olanzapine in an Advanced Cancer Patient: A Case Report. | Go SI et al. | โ | 2018 | โ |
| Defining Substance Use Disorders: The Need for Peripheral Biomarkers. | Bough KJ et al. | โ | 2018 | โ |
| Different patterns of alcohol consumption and the incidence and persistence of depressive and anxiety symptoms among older adults in Ireland: A prospective community-based study. | Carvalho AF et al. | โ | 2018 | โ |
| Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction. | Ji H et al. | โ | 2018 | โ |
| DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. | Kerridge BT et al. | โ | 2018 | โ |
| Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. | Hasin DS et al. | โ | 2018 | โ |
| Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family. | Chatterjee A et al. | โ | 2018 | โ |
| Factors Associated with Sustained Remission among Chronic Opioid Users. | Shiraly R et al. | โ | 2018 | โ |
| Falling rates of marijuana dependence among heavy users. | Davenport S | โ | 2018 | โ |
| From Synapse to Function: A Perspective on the Role of Neuroproteomics in Elucidating Mechanisms of Drug Addiction. | Natividad LA et al. | โ | 2018 | โ |
| Group Psychotherapy in Specialty Clinics for Substance Use Disorder Treatment:The Challenge of Ethnoracially Diverse Clients. | Wendt DC et al. | โ | 2018 | โ |
| Hangover in Post-College-Aged Drinkers: Psychometric Properties of the Hangover Symptom Scale (HSS) and the Hangover Symptom Scale-Short Form (HSS-5). | Chavarria J et al. | โ | 2018 | โ |
| Impulsive dispositions and alcohol: what we know, how we know it, and where to go from here. | Stevens AK et al. | โ | 2018 | โ |
| Independent predictors of mortality in adolescents ascertained for conduct disorder and substance use problems, their siblings and community controls. | Border R et al. | โ | 2018 | โ |
| Intensity of Daily Drinking and Its Relation to Alcohol Use Disorders. | Vergรฉs A et al. | โ | 2018 | โ |
| Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort. | Colizzi M et al. | โ | 2018 | โ |
| Major life events and risk of alcohol use disorders: a prospective cohort study. | Just-รstergaard E et al. | โ | 2018 | โ |
| Medical cannabis: An oxymoron? Physicians' perceptions of medical cannabis. | Zolotov Y et al. | โ | 2018 | โ |
| Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion. | Jouanjus E et al. | โ | 2018 | โ |
| Mental health service utilization is associated with retention in care among persons living with HIV at a university-affiliated HIV clinic. | Saag LA et al. | โ | 2018 | โ |
| Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. | Pitt AL et al. | โ | 2018 | โ |
| Moderation of alcohol craving reactivity to drinking-related contexts by individual differences in alcohol sensitivity: An ecological investigation. | Trela CJ et al. | โ | 2018 | โ |
| Opioids in oral fluid of Spanish drivers. | Herrera-Gรณmez F et al. | โ | 2018 | โ |
| Patient 2 with decompensated cirrhosis due to alcohol with short duration of sobriety. | Lindenmeyer CC et al. | โ | 2018 | โ |
| Patient engagement, treatment preferences and shared decision-making in the treatment of opioid use disorder in adults: a scoping review protocol. | Marshall T et al. | โ | 2018 | โ |
| Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates. | McCabe SE et al. | โ | 2018 | โ |
| Prescription drug use, misuse and related substance use disorder symptoms vary by educational status and attainment in U.S. adolescents and young adults. | Schepis TS et al. | โ | 2018 | โ |
| Prevalence and correlates of arrests or stops for drunk driving on both sides of the U.S.-Mexico border. | Wallisch L et al. | โ | 2018 | โ |
| Prisoners as Patients: The Opioid Epidemic, Medication-Assisted Treatment, and the Eighth Amendment. | Linden M et al. | โ | 2018 | โ |
| Psychosocial factors associated with persistent pain in people with HIV: a systematic review with meta-analysis. | Scott W et al. | โ | 2018 | โ |
| Punishment of alcohol-reinforced responding in alcohol preferring P rats reveals a bimodal population: Implications for models of compulsive drug seeking. | Marchant NJ et al. | โ | 2018 | โ |
| Randomized Clinical Trial of Computerized and Clinician-Delivered CBT in Comparison With Standard Outpatient Treatment for Substance Use Disorders: Primary Within-Treatment and Follow-Up Outcomes. | Kiluk BD et al. | โ | 2018 | โ |
| Reducing Opioid Use for Patients With Chronic Pain: An Evidence-Based Perspective. | Wenger S et al. | โ | 2018 | โ |
| Relation of Cannabis Use and Atrial Fibrillation Among Patients Hospitalized for Heart Failure. | Adegbala O et al. | โ | 2018 | โ |
| Relationship between Tobacco Craving and Quality of Life among French Students: Results of a Cross-Sectional Study. | Bertin C et al. | โ | 2018 | โ |
| Relationship between tonic and phasic craving for alcohol. | Hartwell EE et al. | โ | 2018 | โ |
| Screening emergency department patients for opioid drug use: A qualitative systematic review. | Sahota PK et al. | โ | 2018 | โ |
| Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals. | Moulignier A et al. | โ | 2018 | โ |
| Sources of opioid medication for misuse in older adults: results from a nationally representative survey. | Schepis TS et al. | โ | 2018 | โ |
| Studying Sex Differences in Animal Models of Addiction: An Emphasis on Alcohol-Related Behaviors. | Hilderbrand ER et al. | โ | 2018 | โ |
| Substance-related disorders: A review of prevalence and correlates among patients with chronic pain. | Martel MO et al. | โ | 2018 | โ |
| Substance use and use disorders and treatment receipt among adults in families receiving Temporary Assistance for Needy Families (TANF), 2003-2014. | Oh S et al. | โ | 2018 | โ |
| The crucial role of recovery capital in individuals with a gambling disorder. | Gavriel-Fried B | โ | 2018 | โ |
| The Dangerous Pattern of Concurrent Use of Alcohol and Cocaine Among Drunk-Drivers of Northeast Italy. | Snenghi R et al. | โ | 2018 | โ |
| The Genetic Relationship Between Psychological Distress, Somatic Distress, Affective Disorders, and Substance Use in Young Australian Adults: A Multivariate Twin Study. | Chang LH et al. | โ | 2018 | โ |
| The latent trait of ICD-11 nicotine dependence criteria: Dimensional and categorical phenotypes. | Castaldelli-Maia JM et al. | โ | 2018 | โ |
| The opioid epidemic and pregnancy: implications for anesthetic care. | Raymond BL et al. | โ | 2018 | โ |
| The Psychiatric Consequences of Cannabinoids. | De Aquino JP et al. | โ | 2018 | โ |
| The quality of life when a partner has substance use problems: a scoping review. | Birkeland B et al. | โ | 2018 | โ |
| Typology of new psychoactive substance use among the general Australian population. | Sutherland R et al. | โ | 2018 | โ |
| US Epidemiology of Cannabis Use and Associated Problems. | Hasin DS | โ | 2018 | โ |
| What do we know about the pharmacotheraputic management of insomnia in cannabis withdrawal: A systematic review. | Zhand N et al. | โ | 2018 | โ |
| When should the driver with a history of substance misuse be allowed to return to the wheel? A review of the substance misuse section of the Australian national guidelines. | Ogden EJD et al. | โ | 2018 | โ |
| A commentary on the "eating addiction" versus "food addiction" perspectives on addictive-like food consumption. | Schulte EM et al. | โ | 2017 | โ |
| Age at Immigration and Substance Use and Problems Among Males and Females at the U.S.-Mexico Border. | Cherpitel CJ et al. | โ | 2017 | โ |
| Agreement between DSM-IV and DSM-5 criteria for alcohol use disorder among outpatients suffering from depressive and anxiety disorders. | Bartoli F et al. | โ | 2017 | โ |
| Alcohol Use Patterns and DSM-5 Alcohol Use Disorder on Both Sides of the U.S.-Mexico Border. | Greenfield TK et al. | โ | 2017 | โ |
| A Prospective Comparison of How the Level of Response to Alcohol and Impulsivity Relate to Future DSM-IV Alcohol Problems in the COGA Youth Panel. | Schuckit MA et al. | โ | 2017 | โ |
| A prospective study of the motivational and health dynamics of Internet Gaming Disorder. | Weinstein N et al. | โ | 2017 | โ |
| Area-level disadvantage and alcohol use disorder in northern Mexico. | Orozco R et al. | โ | 2017 | โ |
| A review of caffeine use as a risk or protective factor for women's health and pregnancy. | Peacock A et al. | โ | 2017 | โ |
| A single session of repetitive transcranial magnetic stimulation of the prefrontal cortex reduces cue-induced craving in patients with gambling disorder. | Gay A et al. | โ | 2017 | โ |
| Binge Drinking: Current Diagnostic and Therapeutic Issues. | Rolland B et al. | โ | 2017 | โ |
| Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians. | Copeland WE et al. | โ | 2017 | โ |
| Cannabis use, attitudes, and legal status in the U.S.: A review. | Carliner H et al. | โ | 2017 | โ |
| Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. | Martins SS et al. | โ | 2017 | โ |
| Chronic pain and opioid misuse: a review of reviews. | Voon P et al. | โ | 2017 | โ |
| Clearing the haze: the complexities and challenges of research on state marijuana laws. | Choo EK et al. | โ | 2017 | โ |
| Combining Multiple Resting-State fMRI Features during Classification: Optimized Frameworks and Their Application to Nicotine Addiction. | Ding X et al. | โ | 2017 | โ |
| Commentary on Ostergaard et al. (2017): Evidence of an association between cannabis use and suicide in subjects with bipolar disorder. | Bartoli F | โ | 2017 | โ |
| Commentary on Schmitz et al. (2017): Advancing medication development for addiction-behavioral and neuroimaging outcomes as indirect biomarkers of target engagement. | Farokhnia M et al. | โ | 2017 | โ |
| Comparison of DSM-IV and DSM-5 criteria for alcohol use disorders in VA primary care patients with frequent heavy drinking enrolled in a trial. | Takahashi T et al. | โ | 2017 | โ |
| Compulsive methamphetamine taking under punishment is associated with greater cue-induced drug seeking in rats. | Torres OV et al. | โ | 2017 | โ |
| Co-occurrence of DSM-IV mental disorders and alcohol use disorder among adult Chinese males. | Cheng HG et al. | โ | 2017 | โ |
| Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases. | Warren N et al. | โ | 2017 | โ |
| Drinking despite health problems among individuals with liver disease across the United States. | Elliott JC et al. | โ | 2017 | โ |
| Drinking Status Between Ages 50 and 55 for Men From the San Diego Prospective Study Who Developed DSM-IV Alcohol Abuse or Dependence in Prior Follow-Ups. | Gonรงalves PD et al. | โ | 2017 | โ |
| Drug abusers have impaired cerebral oxygenation and cognition during exercise. | Grandjean da Costa K et al. | โ | 2017 | โ |
| Economic conditions, illicit drug use, and substance use disorders in the United States. | Carpenter CS et al. | โ | 2017 | โ |
| Evaluation of a Pilot Implementation to Integrate Alcohol-Related Care within Primary Care. | Bobb JF et al. | โ | 2017 | โ |
| Frequency of Cannabis Use Among Primary Care Patients in Washington State. | Lapham GT et al. | โ | 2017 | โ |
| Gambling disorder, DSM-5 criteria and symptom severity. | Grant JE et al. | โ | 2017 | โ |
| Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents. | Chung T et al. | โ | 2017 | โ |
| Guidelines for prescribing opioids for chronic non-cancer pain in Korea. | Kim ED et al. | โ | 2017 | โ |
| Internet Gaming Disorder: Investigating the Clinical Relevance of a New Phenomenon. | Przybylski AK et al. | โ | 2017 | โ |
| Intersections of poverty, race/ethnicity, and sex: alcohol consumption and adverse outcomes in the United States. | Glass JE et al. | โ | 2017 | โ |
| Interventional study plan to investigate the training effects on physical and psychological outcomes awareness of smoking in teenagers. | Mohamadian F et al. | โ | 2017 | โ |
| Investigating the separate and interactive associations of trauma and depression on neurocognition in urban dwelling adults. | Karstens AJ et al. | โ | 2017 | โ |
| Is subclinical gambling really subclinical? | Weinstock J et al. | โ | 2017 | โ |
| Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence. | Lalanne L et al. | โ | 2017 | โ |
| Medical Marijuana and Marijuana Legalization. | Pacula RL et al. | โ | 2017 | โ |
| Misdeed of the need: towards computational accounts of transition to addiction. | Keramati M et al. | โ | 2017 | โ |
| [Misuse and dependence on prescription opioids: Prevention, identification and treatment]. | Rolland B et al. | โ | 2017 | โ |
| Neural substrates of cue reactivity and craving in gambling disorder. | Limbrick-Oldfield EH et al. | โ | 2017 | โ |
| Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder. | Gilpin NW et al. | โ | 2017 | โ |
| Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users. | Chye Y et al. | โ | 2017 | โ |
| Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial. | Bradley KA et al. | โ | 2017 | โ |
| Pilot Studies Examining Feasibility of Substance Use Disorder Screening and Treatment Linkage at Urban Sexually Transmitted Disease Clinics. | Gryczynski J et al. | โ | 2017 | โ |
| Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence. | Garcia-Marchena N et al. | โ | 2017 | โ |
| Predictive validity of cannabis consumption measures: Results from a national longitudinal study. | Buu A et al. | โ | 2017 | โ |
| Prevalence and severity of mental disorders in military personnel: a standardised comparison with civilians. | Trautmann S et al. | โ | 2017 | โ |
| Prevalence, Treatment, And Unmet Treatment Needs Of US Adults With Mental Health And Substance Use Disorders. | Han B et al. | โ | 2017 | โ |
| Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders. | Suryadevara U et al. | โ | 2017 | โ |
| Recognizing and Caring for the Intoxicated Patient in an Outpatient Clinic. | Donroe JH et al. | โ | 2017 | โ |
| Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. | Dematteis M et al. | โ | 2017 | โ |
| Relationship between substance use and attitudes towards seeking professional psychological help among veterans filing PTSD claims. | Meshberg-Cohen S et al. | โ | 2017 | โ |
| Scaling-up primary health care-based prevention and management of heavy drinking at the municipal level in middle-income countries in Latin America: Background and protocol for a three-country quasi-experimental study. | Anderson P et al. | โ | 2017 | โ |
| Shelter-Based Opioid Treatment: Increasing Access to Addiction Treatment in a Family Shelter. | Chatterjee A et al. | โ | 2017 | โ |
| Similarities and Differences between Individuals Seeking Treatment for Gambling Problems vs. Alcohol and Substance Use Problems in Relation to the Progressive Model of Self-stigma. | Gavriel-Fried B et al. | โ | 2017 | โ |
| Substance dependence among those without symptoms of substance abuse in the World Mental Health Survey. | Lago L et al. | โ | 2017 | โ |
| Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11. | Saunders JB | โ | 2017 | โ |
| The Mini Alcohol Craving Experience Questionnaire: Development and Clinical Application. | Coates JM et al. | โ | 2017 | โ |
| The potential impact of cannabis legalization on the development of cannabis use disorders. | Budney AJ et al. | โ | 2017 | โ |
| The Role of Adenosine Receptors in Psychostimulant Addiction. | Ballesteros-Yรกรฑez I et al. | โ | 2017 | โ |
| The Role of the Ghrelin System in Drug Addiction. | Zallar LJ et al. | โ | 2017 | โ |
| Three Approaches to Understanding and Classifying Mental Disorder: ICD-11, DSM-5, and the National Institute of Mental Health's Research Domain Criteria (RDoC). | Clark LA et al. | โ | 2017 | โ |
| US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. | Hasin DS et al. | โ | 2017 | โ |
| Usefulness of the CRAFFT to Diagnose Alcohol or Cannabis Use Disorders in a Sample of Emerging Adults with Past-Month Alcohol or Cannabis Use. | Bagley SM et al. | โ | 2017 | โ |
| Virtual Reality Objectifies the Diagnosis of Psychiatric Disorders: A Literature Review. | van Bennekom MJ et al. | โ | 2017 | โ |
| Wanting and Getting Help for Substance Problems on Both Sides of the US-Mexico Border. | Wallisch L et al. | โ | 2017 | โ |
| Addiction History Associates with the Propensity to Form Habits. | McKim TH et al. | โ | 2016 | โ |
| Adolescent Gambling-Oriented Attitudes Mediate the Relationship Between Perceived Parental Knowledge and Adolescent Gambling: Implications for Prevention. | Canale N et al. | โ | 2016 | โ |
| Alcohol use disorders. | Connor JP et al. | โ | 2016 | โ |
| Alcohol use disorders in Australia. | Freyer CH et al. | โ | 2016 | โ |
| A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder. | King AC et al. | โ | 2016 | โ |
| Association of Specific Traumatic Experiences With Alcohol Initiation and Transitions to Problem Use in European American and African American Women. | Werner KB et al. | โ | 2016 | โ |
| Author`s Reply. | Hajsadeghi S | โ | 2016 | โ |
| Black-White Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net? | McElrath K et al. | โ | 2016 | โ |
| Cannabis withdrawal and sleep: A systematic review of human studies. | Gates P et al. | โ | 2016 | โ |
| Centrally Mediated Disorders of Gastrointestinal Pain. | Keefer L et al. | โ | 2016 | โ |
| Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disorders. | Bartoli F et al. | โ | 2016 | โ |
| Combined Effects of Simultaneous Exposure to Caffeine and Cocaine in the Mouse Striatum. | Muรฑiz JA et al. | โ | 2016 | โ |
| Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey. | Lago L et al. | โ | 2016 | โ |
| Craving Mediates Stress in Predicting Lapse During Alcohol Dependence Treatment. | Law B et al. | โ | 2016 | โ |
| Determining optimal diagnostic criteria through chronicity and comorbidity. | Steinley D et al. | โ | 2016 | โ |
| Diagnostic Issues and Controversies in DSM-5: Return of the False Positives Problem. | Wakefield JC | โ | 2016 | โ |
| Differences in childhood physical abuse reporting and the association between CPA and alcohol use disorder in European American and African American women. | Werner KB et al. | โ | 2016 | โ |
| Dual cannabis and alcohol use disorders in young adults: Problems magnified. | Hayaki J et al. | โ | 2016 | โ |
| Effects of added involvement from concerned significant others in internet-delivered CBT treatments for problem gambling: study protocol for a randomised controlled trial. | Nilsson A et al. | โ | 2016 | โ |
| Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Grant BF et al. | โ | 2016 | โ |
| Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications. | Cadet JL | โ | 2016 | โ |
| Exploration of Core Symptoms for the Diagnosis of Alcohol Dependence in the ICD-10. | Yoshimura A et al. | โ | 2016 | โ |
| Gambling behaviors and psychopathology related to Attention-Deficit/Hyperactivity Disorder (ADHD) in problem and non-problem adult gamblers. | Fatseas M et al. | โ | 2016 | โ |
| Gambling Disorder in the DSM-5: Opportunities to Improve Diagnosis and Treatment Especially in Substance Use and Homeless Populations. | Rash CJ et al. | โ | 2016 | โ |
| Health Disparities in Drug- and Alcohol-Use Disorders: A 12-Year Longitudinal Study of Youths After Detention. | Welty LJ et al. | โ | 2016 | โ |
| History of the Concept of Addiction. | Nathan PE et al. | โ | 2016 | โ |
| Internalizing and externalizing disorders as predictors of alcohol use disorder onset during three developmental periods. | Farmer RF et al. | โ | 2016 | โ |
| Measuring tobacco dependence in the general population: Evaluation of the Cigarette Dependence Scale (CDS-12) and its adaptation to smokeless tobacco use (STDS-12) in two Swedish surveys. | Rydell M et al. | โ | 2016 | โ |
| Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders. | Ferrรฉ S | โ | 2016 | โ |
| Meta-analysis of DSM alcohol use disorder criteria severities: structural consistency is only 'skin deep'. | Lane SP et al. | โ | 2016 | โ |
| Mischievous responding in Internet Gaming Disorder research. | Przybylski AK | โ | 2016 | โ |
| Neural substrates of cue reactivity: association with treatment outcomes and relapse. | Courtney KE et al. | โ | 2016 | โ |
| Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States. | Saha TD et al. | โ | 2016 | โ |
| Outcome of patients with dual diagnosis in secondary psychiatric care. | Luoto KE et al. | โ | 2016 | โ |
| Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? | Johnson KA et al. | โ | 2016 | โ |
| Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Hasin DS et al. | โ | 2016 | โ |
| Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review. | Copeland J et al. | โ | 2016 | โ |
| Psychometric modeling of abuse and dependence symptoms across six illicit substances indicates novel dimensions of misuse. | Clark SL et al. | โ | 2016 | โ |
| Psychometric properties of the Brazilian version of the Personal Experience Screening Questionnaire. | Fidalgo TM et al. | โ | 2016 | โ |
| Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe. | Carrร G et al. | โ | 2016 | โ |
| Redefining the Recreational Drug User Population in Human Abuse Potential Studies. | Hopyan T et al. | โ | 2016 | โ |
| [Reduce impact of addictive substances on individual and societal well-being]. | Touzeau D | โ | 2016 | โ |
| [Sleep disorders and addictions: Impact on quality of life and relapse vulnerability]. | Fatseas M et al. | โ | 2016 | โ |
| STREAM: Elucidating How Alcohol Use Disorders are Managed in UK General Practice Today. | Coste F et al. | โ | 2016 | โ |
| Stress psychobiology in the context of addiction medicine: from drugs of abuse to behavioral addictions. | Lemieux A et al. | โ | 2016 | โ |
| Striatum morphometry is associated with cognitive control deficits and symptom severity in internet gaming disorder. | Cai C et al. | โ | 2016 | โ |
| Substance Use Disorders and Schizophrenia. | Manseau M et al. | โ | 2016 | โ |
| Subthreshold problem drinkers in DSM-5 alcohol use disorder classification. | Baggio S et al. | โ | 2016 | โ |
| The Epidemiology of DSM-5 Cannabis Use Disorders Among U.S. Adults: Science to Inform Clinicians Working in a Shifting Social Landscape. | Compton WM et al. | โ | 2016 | โ |
| The Epidemiology of DSM-5 Nicotine Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Chou SP et al. | โ | 2016 | โ |
| The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study. | Alblooshi H et al. | โ | 2016 | โ |
| The Role of Specific Alcohol-Related Problems in Predicting Depressive Experiences in a Cross-Sectional National Household Survey. | McBride O et al. | โ | 2016 | โ |
| Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. | Denis C et al. | โ | 2016 | โ |
| "Addicted to Euphoria": The History, Clinical Presentation, and Management of Party Drug Misuse. | Bearn J et al. | โ | 2015 | โ |
| Adult attention-deficit/hyperactivity disorder: Associations between subtype and lifetime substance use - a clinical study. | Liebrenz M et al. | โ | 2015 | โ |
| Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study. | Degenhardt L et al. | โ | 2015 | โ |
| Alcohol problem recognition and help seeking in adolescents and young adults at varying genetic and environmental risk. | Glass JE et al. | โ | 2015 | โ |
| Border effects on DSM-5 alcohol use disorders on both sides of the U.S.-Mexico border. | Cherpitel CJ et al. | โ | 2015 | โ |
| Cannabinoid abuse and addiction: Clinical and preclinical findings. | Panlilio LV et al. | โ | 2015 | โ |
| [Cannabis use: what to do in general practice?]. | Benard V et al. | โ | 2015 | โ |
| Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects. | Shmulewitz D et al. | โ | 2015 | โ |
| Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults. | Moitra E et al. | โ | 2015 | โ |
| Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in Italy (PADDI)" Study. | Carrร G et al. | โ | 2015 | โ |
| Disorders Related to Use of Psychoactive Substances in DSM-5: Changes and Challenges. | Bhad R et al. | โ | 2015 | โ |
| DSM-5, psychiatric epidemiology and the false positives problem. | Wakefield JC | โ | 2015 | โ |
| DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. | Wakefield JC | โ | 2015 | โ |
| DSM-5 SUD diagnoses: changes, reactions, remaining open questions. | Hasin D | โ | 2015 | โ |
| DSM-IV and DSM-5 alcohol use disorder among young Swiss men. | Mohler-Kuo M et al. | โ | 2015 | โ |
| Effects of caffeine and its metabolite paraxanthine on intracranial self-stimulation in male rats. | Lazenka MF et al. | โ | 2015 | โ |
| Epidemiological Studies of Substance Dependence and Abuse in Adults. | Delker E et al. | โ | 2015 | โ |
| Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. | Grant BF et al. | โ | 2015 | โ |
| Explicit and implicit heroin-related cognitions and heroin use among patients receiving methadone maintenance treatment. | Wang PW et al. | โ | 2015 | โ |
| From DSM-IV to DSM-5 alcohol use disorder: an overview of epidemiological data. | Bartoli F et al. | โ | 2015 | โ |
| Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III. | Kerridge BT et al. | โ | 2015 | โ |
| Good state policy may not mean good pain care, but policy improvement offers hope for further progress: response to the Wahowiak article. | Gilson AM | โ | 2015 | โ |
| How well do the DSM-5 alcohol use disorder designations map to the ICD-10 disorders? | Hoffmann NG et al. | โ | 2015 | โ |
| Inter-observer reliability of DSM-5 substance use disorders. | Denis CM et al. | โ | 2015 | โ |
| Investigating dimensionality and measurement bias of DSM-5 alcohol use disorder in a representative sample of the largest metropolitan area in South America. | Castaldelli-Maia JM et al. | โ | 2015 | โ |
| Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS(ยฎ)): Severity of use and positive appeal of use. | Pilkonis PA et al. | โ | 2015 | โ |
| Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics. | Schmidt TD et al. | โ | 2015 | โ |
| Latent Class Analysis of DSM-5 Alcohol Use Disorder Criteria Among Heavy-Drinking College Students. | Rinker DV et al. | โ | 2015 | โ |
| Liberal alcohol legislation: does it amplify the effects among Swiss men of person-related risk factors on heavy alcohol use? | Foster S et al. | โ | 2015 | โ |
| Limits of Current Approaches to Diagnosis Severity Based on Criterion Counts: An Example with DSM-5 Alcohol Use Disorder. | Lane SP et al. | โ | 2015 | โ |
| Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Goldstein RB et al. | โ | 2015 | โ |
| Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates. | Boscarino JA et al. | โ | 2015 | โ |
| Pain acceptance and opiate use disorders in addiction treatment patients with comorbid pain. | Lin LA et al. | โ | 2015 | โ |
| Performance of the RAPS4/RAPS4-QF for DSM-5 compared to DSM-IV alcohol use disorders in the general population: Data from the 2000-2010 National Alcohol Surveys. | Cherpitel CJ et al. | โ | 2015 | โ |
| Pharmacotherapy for alcohol use disorder: current and emerging therapies. | Swift RM et al. | โ | 2015 | โ |
| Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity. | Pedraz M et al. | โ | 2015 | โ |
| Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. | Araos P et al. | โ | 2015 | โ |
| Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. | Hasin DS et al. | โ | 2015 | โ |
| Primary Care Management of Alcohol Misuse. | Berger D et al. | โ | 2015 | โ |
| Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population. | Hasin DS et al. | โ | 2015 | โ |
| Psychometric assessment of the craving to tan questionnaire. | Ashrafioun L et al. | โ | 2015 | โ |
| PTSD, Depression, Daily Stressors, and Treatment Pathways Among Urban Veterans. | Vazan P et al. | โ | 2015 | โ |
| Risky Drinking, Alcohol Use Disorders, and Health Services Utilization in the U.S. General Population: Data from the 2005 and 2010 National Alcohol Surveys. | Cherpitel CJ et al. | โ | 2015 | โ |
| Role-Playing and Real-Time Strategy Games Associated with Greater Probability of Internet Gaming Disorder. | Eichenbaum A et al. | โ | 2015 | โ |
| Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. | Howell LL et al. | โ | 2015 | โ |
| Sleep Disturbance in Substance Use Disorders. | Roehrs TA et al. | โ | 2015 | โ |
| The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. | Hasin DS et al. | โ | 2015 | โ |
| The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. | Grant BF et al. | โ | 2015 | โ |
| The effect of cross-border mobility on alcohol and drug use among Mexican-American residents living at the U.S.-Mexico border. | Cherpitel CJ et al. | โ | 2015 | โ |
| The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)--a huge resource for data and research findings. | Hasin D et al. | โ | 2015 | โ |
| The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. | Hasin DS et al. | โ | 2015 | โ |
| The New French Guidelines on Alcohol Misuse: An Initiative for Strengthening Cross-European Interplay. | Rolland B et al. | โ | 2015 | โ |
| Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients. | Gryczynski J et al. | โ | 2015 | โ |
| Validation of the MINI (DSM IV) Tool for the Assessment of Alcohol Dependence among Young People in Northern Tanzania Using the Alcohol Biomarker Phosphatidylethanol (PEth). | Francis JM et al. | โ | 2015 | โ |
| Adolescent alcohol use and alcohol use disorders in Mexico City. | Benjet C et al. | โ | 2014 | โ |
| Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study. | King AC et al. | โ | 2014 | โ |
| Alcoholism: diagnosis, prognosis, epidemiology, and burden of the disease. | Beresford TP et al. | โ | 2014 | โ |
| Alcohol use disorder, contexts of alcohol use, and the risk of HIV transmission among South African male patrons of shebeens. | Scott-Sheldon LA et al. | โ | 2014 | โ |
| An international consensus for assessing internet gaming disorder using the new DSM-5 approach. | Petry NM et al. | โ | 2014 | โ |
| A test of the DSM-5 severity scale for alcohol use disorder. | Fazzino TL et al. | โ | 2014 | โ |
| Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis. | Carrร G et al. | โ | 2014 | โ |
| Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment. | Di Nicola M et al. | โ | 2014 | โ |
| Bringing patient-centered care to patients with alcohol use disorders. | Bradley KA et al. | โ | 2014 | โ |
| Cannabis use and anxiety: is stress the missing piece of the puzzle? | Temple EC et al. | โ | 2014 | โ |
| Childhood maltreatment, stressful life events, and alcohol craving in adult drinkers. | Kim JH et al. | โ | 2014 | โ |
| Chronic alcohol self-administration in monkeys shows long-term quantity/frequency categorical stability. | Baker EJ et al. | โ | 2014 | โ |
| Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. | Kelly SM et al. | โ | 2014 | โ |
| Diagnostic challenges in alcohol use disorder and alcoholic liver disease. | Vonghia L et al. | โ | 2014 | โ |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | โ | 2014 | โ |
| [DSM-5: important changes in the field of addictive diseases]. | Heinz A et al. | โ | 2014 | โ |
| DSM-IV alcohol dependence and marital dissolution: evidence from the National Epidemiologic Survey on Alcohol and Related Conditions. | Cranford JA | โ | 2014 | โ |
| Have the genetics of cannabis involvement gone to pot? | Agrawal A et al. | โ | 2014 | โ |
| Impact of substance use disorder on presentation and short-term course of schizophrenia. | Chakraborty R et al. | โ | 2014 | โ |
| Individuals receiving specialized treatment for drug and alcohol dependence and gambling disorder in Israel--characteristics and implications for prevalence estimates. | Lev-Ran S et al. | โ | 2014 | โ |
| Is a 'general' theory of addiction possible? A commentary on: a multistep general theory of transition to addiction. | Badiani A | โ | 2014 | โ |
| Neurocognitive moderation of associations between cannabis use and psychoneuroticism. | Huijbregts SC et al. | โ | 2014 | โ |
| Parental psychopathology moderates the influence of parental divorce on lifetime alcohol use disorders among Israeli adults. | Thompson RG et al. | โ | 2014 | โ |
| Polysubstance use: diagnostic challenges, patterns of use and health. | Connor JP et al. | โ | 2014 | โ |
| Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder. | Glass JE et al. | โ | 2014 | โ |
| The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination. | Mitchell SG et al. | โ | 2014 | โ |
| The Genetics, Neurogenetics and Pharmacogenetics of Addiction. | Demers CH et al. | โ | 2014 | โ |
| The management of substance abuse in the critically ill. | Patel G | โ | 2014 | โ |
| Truth or consequences in the diagnosis of substance use disorders. | Martin CS et al. | โ | 2014 | โ |
| Truth (validity) and use despite consequences: the DSM-5 substance use disorder unidimensional syndrome. | Hasin D | โ | 2014 | โ |
| Variants near CHRNB3-CHRNA6 are associated with DSM-5 cocaine use disorder: evidence for pleiotropy. | Sadler B et al. | โ | 2014 | โ |
| Alcohol stigma and persistence of alcohol and other psychiatric disorders: a modified labeling theory approach. | Glass JE et al. | โ | 2013 | โ |
| Commentary on Tuithof et al. (2013): Implications of the DSM-5 revision for the analysis of persistence/remission of alcohol use disorder. | Dawson DA | โ | 2013 | โ |